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ABSTRACT  
   
Bioimpedance measurements have been long used for monitoring tissue ischemia and 
blood flow. This research employs implantable microelectronic devices to measure impedance 
chronically as a potential way to monitor the progress of peripheral vascular disease (PVD). 
Ultrasonically powered implantable microdevices previously developed for the purposes of 
neuroelectric vasodilation for therapeutic treatment of PVD were found to also allow a secondary 
function of tissue bioimpedance monitoring. Having no structural differences between devices 
used for neurostimulation and impedance measurements, there is a potential for double 
functionality and closed loop control of the neurostimulation performed by these types of 
microimplants. The proposed technique involves actuation of the implantable microdevices using 
a frequency-swept amplitude modulated continuous waveform ultrasound and remote monitoring 
of induced tissue current. The design has been investigated using simulations, ex vivo testing, 
and preliminary animal experiments. Obtained results have demonstrated the ability of 
ultrasonically powered neurostimulators to be sensitive to the impedance changes of tissue 
surrounding the device and wirelessly report impedance spectra. Present work suggests the 
potential feasibility of wireless tissue impedance measurements for PVD applications as a 
complement to neurostimulation. 
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CHAPTER 1 
INTRODUCTION 
At the present state of technology, tissue electrical bioimpedance measurements are 
performed using wired systems by placing surface electrodes on the tissue of interest for current 
injection and voltage measurements. In case of conventional non-invasive bioimpedance 
measurements, the system is sensitive to the greatest extent to impedance changes occurring 
near the surface of the skin, whereas deeper tissues can be of the greater interest. From the 
practical point of view, presently available and clinically used bioimpedance measurement 
systems are bulky and are not meant to be used for chronic measurements outside the clinic by 
untrained users. 
Present work entertains the idea of chronic, wireless impedance measurements by 
means of ultrasonically powered implantable neurostimulation devices. Whereas proposed 
microimplant’s based approach is invasive by its nature, tissue damage and patient discomfort 
would be reduced to the minimum by device miniaturization and simplification of the implantation 
procedure. Injection is considered as one of the envisioned methods of implantation. The benefits 
of the investigated approach involve ability to measure impedance chronically at the point of 
interest, i.e. in the area of tissue exposed to the greatest physiological alternations and being of 
the greatest clinical relevance. 
The devices of the type used in this work previously have been investigated only for 
neurostimulatory applications. One of the major applications envisioned for the proposed 
impedance measurement technique involves monitoring of tissue perfusion. Though, the more 
ambitious goal is to apply this technique for indirect monitoring of neural activity by measuring the 
transient resistance changes occurring during neural events. This relates to the idea of closed-
loop functionality and bidirectional communication with the nervous system, allowing feedback 
control of device operation. 
The most common way of performing neural stimulation is by using implantable battery-
powered pacemaker-like devices. Recently, these types of devices have been equipped also with 
neural recording functionality. Still, despite the dramatic improvements of the quality of life 
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delivered to the patients suffering from such disorders as epilepsy or Parkinson’s disease, this 
type of technology is associated with significant discomfort of the user. This discomfort is caused 
by the relatively big dimensions of commonly used devices surgically placed beneath the skin. 
Moreover, these devices require regular inductive recharging of the batteries, as well as recurrent 
surgery once every 3-5 years to replace the batteries. 
In case of neural recording performed for research purposes or control of the prostheses, 
the state of the art technology involves placement of the tethered electrodes into nervous tissue 
with lead wires tunneled through the skin. This leads to even more severe limitations of this 
technology compared to the previously described implantable pacemaker-like devices. In this 
case, transcutaneous wires introduce significant risk of infection. Furthermore, tethering causes 
additional damage to the tissue, as well as degrades the quality of the neural recording over time. 
Consequently, the notion of wireless power delivery and wireless communication gained 
increased interest in the recent years. A lot of work has been done in the attempt of developing 
wirelessly powered implantable neural devices serving either for monitoring or therapeutic 
purposes. Such novel types of devices can be characterized by a range of clinically relevant 
advantages over presently available technologies. These potential advantages include:  
• reduced risk of infection as a consequence of elimination of the transcutaneous 
wires; 
• reduced patient discomfort associated with tethering of the lead wires tunneled 
beneath the skin, increased patient mobility and overall quality of life; 
• reduced injury and post-surgical recovery after implantation; 
• simplified implantation procedure; 
• reduced dimensions can allow more dense and chronic stimulation or recording 
from multiple sites; 
• reduced degradation of performance over time and improved quality of recording 
or stimulation. 
Wireless powering can involve utilization of electromagnetic waves, acoustic waves, and 
harvesting of body motion, thermal or chemical (blood glucose) energy. All these modalities will 
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be addressed in the review of background literature, but the key emphasis in the present work is 
on the power transfer by means of acoustical waves. 
One of the potential applications for the investigated technique is related to the condition 
called Peripheral Vascular Disease (PVD). PVD is a serious healthcare burden caused by the 
atherosclerosis of the limb arterial circulation, accounting for about 3 billion dollars of healthcare 
expenditures and around 60,000 lower limb amputations each year in the United States alone 
[39]. This disease is severed by the increased danger of limb loss and pain [40-41]. During the 
progress of PVD tissue perfusion becomes decreased, causing tissues ischemia and hypoxia. In 
turn, previous studies have demonstrated high sensitivity of tissue bioimpedance measurements 
to ischemia and hypoxia [42-43],[45-47],[50-51], making it a potential indicator of tissue condition, 
treatment efficacy, and stage of the disease. 
Although, results of the studies demonstrating impedance sensitivity to tissue perfusion 
are widely available, any attempts to use impedance measurement technique for monitoring of 
tissue perfusion with PVD have not been reported, adding extra value to present study. 
Furthermore, investigated technique has one more highly significant advantage, which follows 
from the fact that devices of the same type as used in the present work are capable of inducing 
vasodilation and increasing tissue perfusion [2]. This in turn can be used as a treatment of PVD. 
Consequently, the ultimate medical solution envisioned in this work involves closed-loop system 
capable of both treatment and monitoring of PVD. The envisioned idea and principle of work are 
summarized on Fig. 1. 
Taking into consideration all said above, the main goal of the present work was to 
investigate the possibility of wireless impedance measurements using ultrasonically powered 
microdevices. This question is addressed by means of the simulations, benchtop testing and 
animal experiments, involving the assessment of the ability of system to provide spectral 
characterization of the samples and differentiation between tested samples. This study is a first 
step in assessment of the applicability and feasibility of proposed technique, forming a bridge to 
the ultimate goal of development of the multi-functional wireless microdevices. 
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Fig. 1. Illustration of the overall idea behind envisioned application of wireless microdevices for 
monitoring of tissue ischemia. 
  5 
CHAPTER 2 
BACKGROUND AND LITERATURE REVIEW 
Implantable microdevices 
From [10-11], [13], [17-19] it is possible to identify some common most desirable 
characteristics of implantable devices: small sizes (10-100 µm), significantly reduced or 
eliminated risk of infection, no degradation of performance over time, elimination of tethering, high 
density, simple implantation, no limitations for mobility of the patient. To meet these requirements 
microscale implants must be characterized by low power consumption. In order to successfully 
address all these requirements, conventional powering using transcutaneous wires or bulky 
pacemaker batteries with restricted lifespan cannot be used. Wirelessly powered passive devices 
investigated in the present work can be considered as the potential solution addressing these 
needs. 
 
Wireless power transfer 
Wireless powering and communication plays a major role in the process of further 
advancement of the existing implantable technologies. Wireless, passive and implantable 
microelectronic devices of millimeter and sub-millimeter size can be realized and a number of 
different approaches have been proposed. These include wireless powering by light, microwaves, 
epidermically applied high frequency currents, or ultrasound [1-27], [29-32]. The smallest of these 
can pass through a syringe needle, so minimizing trauma of insertion. Alternatively, some work 
has been done on the energy harvesting from the host organism itself [19],[33-34]. Examples of 
such systems include piezoelectric energy harvesting of internal tissue motion, thermoelectricity 
based batteries and glucose bio-fuel batteries utilizing glucose from the blood. The general 
review of the majority of environmental and human energy harvesting techniques is given in [18-
19]. In turn, the review of the wireless powering paradigms is given in [20] and [21]. 
Methodologically four main types of wireless energy transfer can be identified, proposed 
to be applicable for medical implantable devices: optical powering, volume conducted high 
frequency currents, acoustic powering, and radiofrequency (RF) or microwave powering.
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Radio and microwave powering can be sub-divided into power transfer trough capacitive and 
inductive coupling (Fig. 2). 
Optically powered microdevices can be made utilizing near-infrared (NIR) spectrum light 
for wireless power transfer. The choice of this part of the spectrum follows from relatively low 
absorption and scattering of the NIR light by tissue. Effective light conversion into electric currents 
can be achieved by employing semiconductors. In [29] authors have reported the ability to 
produce muscle activation via stimulation of the rat’s spinal cord gray matter using floating light-
activated microelectrical stimulators (FLAMES). The smallest tested device had the size of 140 
µm x 500 µm and thickness of about 100 µm. The device was implanted approximately 2.35 mm 
below the dorsal pial surface into rat’s spinal cord. The largest forces produced by rat’s upper 
limb were around 1.08 N. Despite lower attenuation of NIR light by tissue compared to visible 
light, in their latter work [30] authors demonstrated that the intensity was reduced to 1.85% of the 
subdural intensity after passing through 1 mm of tissue and to 0.15% at 2 mm. In addition to the 
low penetration depth, this technique is associated with significant temperature increase near the 
surface where the photons enter the tissue. 
Utilization of the epidermically applied volume conducted high frequency currents has not 
received much support due to the concerns associated with direct tissue exposure to electrical 
currents, and apparent problems associated with achieving sufficient power density at the target 
 
Fig. 2. Wireless power transfer modalities. 
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area of tissue, as well as difficulties with ensuring multi-channel operation. This technique relies 
on the utilization of the innocuous high frequency currents conductively supplied to the tissue to 
power up the implants and produce low frequency currents [32]. 
Capacitive coupling is the form of electromagnetic powering used for energy and data 
telemetry (purely electric near field coupling) [19], [26]. In its basic form, described in [26], 
approach is based on two parallel aligned plates that behave as capacitor. Capacitive link 
ensures information or energy transfer via electrical fields through the skin, which acts as a 
dielectric media between two capacitive plates. This approach is characterized by a good 
confinement of the electromagnetic flux, but very restricted powering distance. In [26] the radio 
frequency (up to 18 MHz) range waves were used to analyze the powering efficiency through 1 
mm of tissue. Authors demonstrated that by using 25 mm x 25 mm plates it is possible to induce 
wirelessly up to 2 V DC voltage. Methodologically different approach involving capacitive 
powering was proposed in [3]. Instead of the capacitor’s plates-like antennas, proposed devices 
were made in the form of small dipoles with a length of about 1 cm and 800 µm or less in 
diameter, activated using sub-GHz frequencies. Dipole-like devices are capacitively coupled to a 
body surface dipole antenna through electric fields. The implant incorporates low-threshold 
Schottky diode to produce rectification of the high-frequency radiowave and turn it into high-
frequency pulsating DC applicable for neural stimulation. The ability to cause motor response in 
rat was demonstrated with external antenna located as far as 7 cm away in the air. 
 
Fig. 3.  Illustration of wireless microdevice with different modalities of wireless energy delivery.  
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Inductive power transfer (purely magnetic near field coupling) [13], [16-19], [27], [31], 
[35]. This is the simplest powering scheme employing two mutually-coupled coils: radio frequency 
electromagnetic field is carried from the external source coil to the receiving coil on the implant 
side (in most studies frequencies below 20 MHz are utilized). The key difference from the 
capacitive coupling is that inductive powering depends primarily on the magnetic field component 
of the EM wave and not as much on the electric component. Since tissue loss is negligible at low 
frequencies, the power transfer efficiency depends only on the properties of coils - the sizes and 
the distance between them (this distance is typically restricted to the near field of the source 
being equal or less than the wavelength). The closer and bigger is receiver coil, the greater is 
power transfer efficiency. This powering modality for long time has been considered as the most 
promising and effective one, until recently more miniscule devices became highly desirable. One 
of the reasons for wide-spread of this technique is the fact that involved magnetic fields do not 
interact with biological matter, although induced Eddy currents still can have heating effects.  
Furthermore, tissue absorption increases with frequency, resulting in exponential decay 
of the electromagnetic fields inside tissue. This observation led to the conclusion that low MHz-
range is most optimally suited for electromagnetic powering. Cochlear implants can be mentioned 
as the most common system utilizing this powering modality [35]. In the recent years, low GHz-
range electromagnetic wave powering became the target for intensive investigations [22-25]. The 
important conclusion was made suggesting that for the sub-millimeter size devices the optimal 
frequency is about 2 orders of magnitude higher than the commonly used range of low-MHz 
frequencies. The optimal frequency was concluded to be in the GHz-range when the dimensions 
of the transmit antenna are much smaller than a wavelength. Simulations performed in [25] 
demonstrated that transition to high frequencies can allow reduction in the dimensions of the 
receiver by 100 times, while maintaining the same power transfer efficiency. Besides that, authors 
highlight reduced displacement and orientation sensitivity with high frequency powering mode. In 
[25] the technique called midfield wireless powering was proposed, which employs 
electromagnetic induction coupling without exponential decay. The key difference realized in this 
technique lies in the design of external coil. Instead of the usual coil of wire, they used a 
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patterned metal plate with 4 ports. This plate is driven by much higher power than conventional 
inductive powering wire coils, but 4 port antenna design allows cancellation of the side lobes of 
the electromagnetic waves in tissue, allowing only central portion of the beam to reach the 
implant. This can be considered as a form of electromagnetic focusing, producing higher power 
density in the area of interest and reduced amount of power dissipated in the tissue. This helps to 
maintain delivered radiation levels within the FDA limits. Additional benefit of this technique 
relates to the ability of beam steering by controlling the powering of the excitation coil. At this 
point, 2 mm big pacemaker device with 6 mm by 6 mm external excitation coil was tested in the 
rabbits, demonstrating 0.1 percent power transfer efficiency, which is sufficient for typical 
pacemaker applications. 
The idea of acoustic powering received a lot of attention in the last decade [1-2], [4], [6], 
[10-13], [15]. In the past this technique was overlooked due to the fact that electromagnetic 
powering demonstrates more superior performance for short range powering using big aperture 
antennas. Only upon scaling of the implantable devices down to sub-millimeter sizes the high 
potential of acoustic power transfer became evident. This approach relies on energy transmission 
between two piezoelectric transducers through acoustically coupling medium. Piezoelectric 
materials can convert ultrasound to electric power at efficiencies on the order of 10% under good 
conditions. The benefits of ultrasonic powering lies in the fact that the speed of acoustic waves in 
tissue (in soft tissues on average 1540 m/s) is much smaller than speed of electromagnetic 
waves (3x108 m/s), allowing the utilization of ultrasound waves with much lower frequencies. 
Additionally, acoustic waves can be easily focused, reducing the amount of dissipated power and 
increasing the energy density delivered to the specific spot in the tissue. This potentially allows 
separate activation of the multiple implants through beamforming techniques [12], which is 
important for multichannel functionality. The benefits of the ultrasound are manifested by the fact 
that FDA defined limit for the spatial-peak temporal-average intensity (ISPTA) of the ultrasound is 
72 times greater (720 mW/cm2) [36-37] than approved limit for electromagnetic waves (10 
mW/cm2) [10]. Finally, tissue attenuation of the ultrasound is significantly lower than attenuation 
of the high frequency EM waves. Path losses of ultrasound as it passes through tissue vary 
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depending on the frequency and the tissue type, but typical losses might be on the order of 1-5 
dB/cm. For instance, as was shown in [10], by passing through 2 mm of brain tissue, the 
attenuation of 10 MHz ultrasound waves is on the order of 1 dB, whereas for 10 GHz 
electromagnetic waves it is on the order of 20 dB. 
Ultrasound energy at medical diagnostic frequencies in the range of 1-10 MHz is strongly 
attenuated by air and bone, and thus, like ultrasound imaging, is limited to the specific parts of the 
body. Lower frequencies in the range of 500 kHz - 1MHz are generally more suited to powering 
implanted devices where bones may interfere such as the skull. The tradeoff is that lower sound 
frequencies carry a lower energy density and they cannot be focused to the implant location as 
finely as higher frequencies. 
In the literature only two actual attempts of building acoustically powered implantable 
microdevices could be identified. The first one dates to 2003 [1] when utilization of the ultrasound 
powering for implantable devices was proposed and later demonstrated direct conversion of 
ultrasound energy to neurostimulation pulses. Since then, only recently in 2013 the team from UC 
Berkeley proposed so called “neural dust” system. This idea attracted a lot of attention due to the 
huge interest and clinical need for proposed wireless 100 µm neural devices capable of fully 
chronic and highly dense recordings. The key problem associated with this proposal is the fact 
that this idea still resides at the modelling stage and only results of the unsuccessful attempts of 
acoustic data transfer were recently presented in 2014 [11]. Still, this modality of wireless 
powering exhibits a lot of promise for neural applications. 
 
Electrical bioimpedance measurements 
Wirelessly powered implantable microdevices are most commonly considered only for 
neurostimulation and neural recording applications. Present work entertains the idea of the new 
potential application for wirelessly powered implants – electrical impedance measurements. 
Therefore, a brief review of the electrical bioimpedance measurement principles and applications 
is provided. 
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The simplest way how tissue electrical impedance can be measured relies on utilization 
of two surface electrodes serving for both constant current injection and voltage measurements. 
Alternatively, constant voltage can be applied to the tissue and resulting currents measured for 
impedance estimation, but this alternative is not supported due to the safety concerns associated 
with application of the currents of not constant magnitude. The bipolar measurement technique is 
especially sensitive to the changes in electrode-tissue interface, making so called tetrapolar 
impedance measurement technique more appropriate. This technique involves utilization of two 
pairs of electrodes for current injection and voltage measurements. In reported work on 
impedance measurements [42-52] applied subthreshold current is in the range of 10-500 
microamperes, but typical value is considered to be 1 mA/cm2. This range is so broad due to the 
fact that the majority of applications involve current application through the skin associated with 
the skin resistance as high as hundreds of kOhms (depending on humidity, cleanliness, etc.) and 
thus requiring much higher currents, whereas applications involving electrode placement directly 
to the exposed tissues require smaller currents.  
Effective tissue characterization typically requires multiple frequency impedance 
measurements (impedance spectroscopy), which allows differentiation between different tissue 
types and conditions based on the impedance spectra. Impedance spectra are known to have 
four dispersions associated with contributions of the certain tissue forming elements (e.g. α 
dispersion in frequency range below ~100 Hz is considered to be contributed by nucleic acids, 
surface charged vesicles, cell tubular system, surface charge and membrane relaxation) [50-51]. 
Single frequency measurements have also been used, but they allow only monitoring of the 
trends of impedance changes and not the estimation of absolute impedance values. This is due 
to the fact that a large number of variables can affect the single frequency tissue impedance. 
The most successful applications of tissue bioimpedance measurements are impedance 
cardiography and body composition analysis [48], but many other physiologic parameters and 
conditions have been under investigation [52]: 
• non-invasive blood glucose level estimation [28]; 
• blood flow (e.g. impedance plethysmography, impedance phlebography); 
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• eye movements; 
• muscular contractions; 
• vascular impairments (e.g. estimation of the pulse transit time by means of the 
impedance and ECG measurements as an indicator of the condition of vascular system 
[55]); 
• body fluid shifts (pulmonary oedema or intrathoracic fluid, blood volume changes); 
• respiratory function; 
• cancer (especially breast and skin cancers) [49]; 
• cerebral monitoring (attempts are made to detect epilepsy onset or determine 
significance of stroke damage [44], as well as to monitor neural activity non-invasively 
through measurements of resistance changes during neuronal depolarization in the brain 
[56-57]); 
• guidance of the physical intervention (impedance measurements were proposed for 
needle guidance by determining what type of tissue needle is passing through) [54]; 
• tissue ischemia and hypoxia (this includes tissue ischemia and hypoxia assessment in 
the various parts of the body from the brain to the heart) [42-43], [46-47], [50-51]; 
• neurostimulation (study was done trying to utilize impedance measurements to determine 
current threshold required for stimulation) [53]. 
It is important to highlight that the key problem of impedance measurements is 
associated with non-specificity of impedance variations, i.e. different causes can produce 
absolutely the same impedance changes (e.g. temperature changes, changes in electrode 
contact or polarization). This fact significantly limits the ability of impedance measurements to 
give quantitative repeatable results and clinical applicability of this technique. 
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Tissue ischemia monitoring 
Following the previous studies done in our lab, one potential application for impedance 
measurement technique investigated in the present work is peripheral vascular disease (PVD). 
This condition involves reduction in tissue perfusion. For the purpose of this work tissue ischemia 
monitoring techniques are reviewed.  
Ischemia is condition of reduced oxygen (hypoxia) and nutrient supply to the tissue due 
to the constriction or obstruction of blood vessels. Tissue hypoxia is directly related to ischemia in 
the way that ischemia always results in hypoxia, but hypoxia can be present also in the case of 
fully functional cardiovascular system due to the problems with pulmonary system.  
The review of the available tissue ischemia monitoring techniques is given in [51]. Some 
examples of these techniques are laser Doppler, pH measurements, angioscopy, MRI diffusion 
mapping and ankle-brachial index estimation. In [50] and [51] authors reviewed the 
characteristics of ideal ischemia monitor. The best fulfillment of these requirements demonstrated 
pH measurements based technique. In [50] and [51] the correlation between impedance and pH 
measurements was investigated, and correlation was demonstrated to be as high as 0.93. This 
result highlights high feasibility of impedance technique for ischemia monitoring. 
Several researchers have demonstrated apparent impedance correlation to ischemia and 
hypoxia. The only difficulty with interpretation of these observations lies in the fact that different 
studies involve different system setups and parameters, leading to different results. More 
importantly, none of these measurements involved electrodes similar to the ones used within 
present work, making the comparison of the tissue impedance values difficult. 
In [43] evolution of the transencephalic cerebral resistance was demonstrated in seven 
asphyxiated piglets at 50 kHz using four silver rod rough surface electrodes of 2.5 mm diameter 
drilled into skull. The resulting impedance magnitude change after 50 minutes of hypoxia was as 
high as 120 percent with the mean resistance value of 56.2 Ω. In [46] the needle-type impedance 
and pH sensor was designed to measure impedance in rat kidney at 1 kHz during the occlusion 
period of 60 min. During whole period of occlusion impedance was gradually increasing and 
resulting change was again as high as 120 percent, but the baseline impedance in this case was 
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on the order of 1500 Ω. In [50] authors performed correlative study involving pH and impedance 
measurements. This study involved 29 rabbits, whose leg perfusion was controlled by a vascular 
occluder, placed over a femoral artery and vein. Impedance measurements were done using 
needle electrodes and spectra were recorded at 27 frequencies, allowing estimation of the 
various impedance related parameters. One of the estimated parameters was instantaneous 
resistivity at zero frequency (Ro), which in the typical experiment after 108 min long occlusion 
changed by about 16%. This is the only reported case when observed changes were so small, 
but in contrast to previous cases, Ro was estimated, not measured, and its mean value was 
determined to be around 60 Ω. The important conclusion of this work was that ischemia can be 
detected even more accurately using tissue impedance measurements than by measuring pH. In 
[51] Songer et al. demonstrated direct correlation of tissue pH measured invasively with 
impedance measured externally using disposable wet gel ECG electrodes (the selection of the 
electrodes was supported by their low noise level ≤5% in the frequency range of interest between 
1 kHz and 100 kHz). These data were obtained from 15 bloodless human surgeries of the lower 
limbs. Again, estimated baseline average Ro was shown to be around 60 Ω, and although authors 
have not produced excessive ischemia cases themselves, literature survey performed by the 
authors indicated that ischemia causes the resistivity of the muscle tissue to increase by as much 
as 30% almost immediately after the onset of ischemia.  
The cellular changes underlying discussed increase trends were concluded to involve the 
shifts of fluid volume within tissue from extracellular to intracellular space. Cell membranes act as 
capacitors, meaning that low frequency currents are dependent only on extracellular current 
pathways. Cell swelling leads to the narrowing of the extracellular conducting pathways and 
consequent increase in low frequency electrical impedance [51]. 
 
Background work 
 An extensive work has been done in our lab exploring applicability of acoustically 
powered devices for neural stimulation [1-2], [4], [6], [8]. Additionally, as it has been discussed 
before, microwave powered devices have also been proposed by our lab [3], [5], [7] with potential 
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applications both in neural recording and stimulation. Still, as it was demonstrated previously, 
microwave and acoustic powering involve different advantages and disadvantages (e.g., 
ultrasound is greater attenuated by bone, but microwaves by soft tissues), and final conclusions 
about applicability of one technique over another for specific applications are still to be 
formulated.  
For the purposes of neurostimulation both types of devices have demonstrated the ability 
to produce currents on the milliampere order: 
• acoustically powered device made of PZT-5A, with a 1.3 mm diameter and about 10 mm 
length was shown as capable of producing milliampere order currents in Sprague-Dawley 
rat. Device was placed next to the sciatic nerve about 10 mm deep in the tissue and it 
was actuated using average ultrasound power levels between 10 mW/cm2 and 100 
mW/cm2 [2]. Used power level was significantly lower than FDA approved safety limit 
(average power limit is 720 mW/cm2), suggesting possibility of further scaling down of the 
device dimensions by utilizing higher power levels; 
• microwave powered device with dimensions on the order of 0.8 mm in diameter and 1.5 
cm length driven at 915 MHz demonstrated the capability to produce milliampere-order 
currents at 7 cm tissue depths when pulsed at 10 W peak power [3]. 
From these results it can be seen that both powering modalities allow achieving sufficient 
current levels for impedance measurements. Still, there is a number of considerations related to 
these two powering modalities, which have led to our favoring of the acoustically powered 
devices. One of the advantages of microwave powering is absence of requirement for physical 
coupling of antenna with tissue. The second advantage is a much weaker directional sensitivity, 
 
Fig. 4.  Microwave powered dipole devices [3]. 
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which to certain extent is present in all powering modalities. If we consider the actual way how 
microwave powered system would be used, it seems attractive to have an ability to perform 
patient treatment without being required to maintain a stable physical coupling with the patient. 
Still, if these devices are expected to be used chronically then we would need to mount the 
excitation antenna with all supporting circuitry to the body of the patient anyway. This 
consideration minimizes all potential gains from the first advantage of microwave powered 
devices. Moreover, there is a set of disadvantages associated with devices relying on microwave 
energy transfer: 
 the safety concerns associated with tissue exposure to electromagnetic waves (the main 
of which usually relates to the heating effects) are much greater than for the acoustic 
waves. As it was mentioned earlier, the power density limit for the microwaves is 10 
mW/cm2, whereas for ultrasound it is 720 mW/cm2; 
 another observed issue was related to the interference of the powering signal with 
surrounding telecommunication systems, particularly commonly used wireless 
communication channel of 2.45 GHz (although in our devices 915 MHz frequency was 
used, wireless routers were still able to pick up test signals due to the imperfections in 
their construction); 
 at this point it seems to be much more difficult to achieve effective multichannel 
operation of microwave powered devices. The most straightforward approach would be 
tuning of the devices to certain frequency, which in reality is significantly complicated by 
the damping of the Q of the devices by the tissue. In case of acoustic powering, fine 
focusing capabilities potentially allow to utilize beamsteering to activate devices 
separately; 
 presently, the lowest achievable dimensions of microwave powered devices seem to be 
on the higher end than for the ultrasonically powered devices. The energy transfer 
efficacy is higher at wavelengths comparable to device dimensions, favoring the much 
shorter ultrasound wavelengths in tissue. This also relates to the additional benefit of 
ultrasound involving much more effective focusing capabilities; 
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 battery drain for the powering of external exciter was observed to be much greater in 
case of the microwave system, which can become a serious problem in continuous 
everyday applications. 
All these considerations switched the focus of the present work to ultrasonically powered 
devices. Although, in theory the same technique investigated in this work potentially can be 
realized using microwave powered devices. 
One of the potential applications of wirelessly powered devices was reported by our lab in 
[2]. It was shown that these types of devices are able to produce modulation of the blood flow at 
sub-motor activation current levels applied to the rat’s sciatic nerve of the lower limb. In [2] two 
trials were made right after the implantation and two weeks after the implantation, resulting in 
25.1% and 13.8% changes in perfusion, respectively. These changes can be even greater in 
case of longer stimulation, as well as in cases of diseased subjects. These observations allowed 
authors to conclude the feasibility of acoustically powered devices for treatment of peripheral 
vascular disease. 
Preceding work formed the basis for potential application of the presently investigated 
technique of wireless impedance measurements for monitoring of the peripheral vascular 
disease, as well as potential feedback control of the neurostimulatory treatment of this condition. 
The idea of dual functionality and feedback control seems to be feasible due to the fact that there 
are no structural differences between microdevices used for neurostimulation and impedance 
measurements. The only difference is associated with device actuation, output signal 
measurements and analysis. 
In this work we find that a variant of our previously reported ultrasound powered 
neurostimulator allows, with appropriate supporting external circuitry, the measurement of the 
magnitude and phase of impedances. This approach involves microdevice actuation with 
baseband frequency swept AM carrier ultrasound and consequent generation of demodulated 
current proportional to tissue impedance. Volume conduction is then used for signal detection and 
extraction of impedance information. 
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CHAPTER 3 
METHODS AND MATERIALS 
Construction of acoustically powered microdevices 
Photographs of some of the devices built in the process of this work are shown on Fig. 5. 
Fig. 6 shows the basic assembly of components in three different structures considered within 
present work. Implantable neurostimulators were constructed using Magni-Focuser (power of 
3.50 X; Edroy Products Co., Inc) to assemble the electronic components, and then inserted and 
encapsulated in polyimide tubing. Tubing was filled with the medical grade epoxy (353ND, Epoxy 
Technology). In all cases device contained piezoelectric element PZT-5A and two wire-type 
platinum iridium (PtIr) electrodes. All interconnections of the components were made using 
conductive silver epoxy. For the longer distances golden wires were used. For the purposes of 
rectification and demodulation of the electrical current produced by piezoelectric element, three 
different types of rectifiers were used: 
• the Schottky diode (e.g., CDC7630, Skyworks Solutions, Inc.). It has a low threshold 
voltage and a small SC-79 package; 
• the full bridge rectifier diode (e.g., Bridge Quad HSMS-2818-TRIG; forward threshold 
voltage of 410 mV and reverse breakdown voltage of 20 V; dimensions 3 mm x 1 mm x 
2.5 mm). It can be characterized by a higher threshold voltage caused by the fact that it 
incorporates four diodes (in contrast to one in the previous case), which are 
interconnected in a bridge circuit configuration. The idea is that such arrangement 
provides the same polarity of output for either polarity of input (performs full-wave 
rectification). Consequently, as this configuration incorporates four diodes it is associated 
 
 
Fig. 5.  Photographs of the acoustically powered microdevices. 
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with the greatest dimensions; 
• the variable capacitance (i.e., varactor or varicap) diode (e.g., 5mV 1240-074LTF, 
Skyworks Solutions, Inc.; capacitance of 54.6 pF). The capacitance of this diode varies 
as a function of the voltage applied across its terminals. The type of the varactor used 
within present work incorporates two diodes connected back-to-back, providing it the 
medium dimensions between two previous types of rectifiers. 
The reasoning behind considering these types of rectifiers, as well as an overview of 
performance of the devices incorporating these configurations, is provided within the results and 
discussion sections on system characterization. 
Some details regarding construction and operation of the Schottky diode based devices 
are available in [1-2], [4] and [6]. 
It is important to emphasize that devices constructed and used within present work are 
bigger than potentially achievable device dimensions. This is related to the fact that the goal of 
this work does not involve development of the final optimal clinically applicable system. Instead, 
present work is focused on proving and demonstrating the ability of proposed technique to detect 
impedance changes. All further system sophistication and optimization is the aim for future work. 
Within the framework of this work, the smallest constructed device was 6.35 mm in length (plus 
the length of the electrodes 2.50 mm) and 1.14 mm in diameter.  The smallest PZT-5A crystal 
tested within this work had the dimensions of 350 µm x 300 µm x 127 µm, which in case of being 
driven by continuous waveform with acoustic power density around 190 mW/cm2 
 
 
Fig. 6.  Schematics of microdevices. A-1 and A-2 – variations of the single diode based device, B – full-
wave rectifier based device, C – varicap diode based device. 
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generated voltages on the order of 110 mV (details of these measurements are not further 
discussed within this work). 
 
Principle behind wireless impedance measurements 
The main idea behind the proposed impedance measurement technique investigated 
within present work is summarized on Figure 7A. Full sequence of the physical processes 
involved in the measurement procedure can be divided into six main steps: 
1. Conversion of the externally supplied amplified amplitude modulated (AM) electrical 
driving signal (carrier) into ultrasound waves using piezoelectric transducer. Ideally, 
generated acoustic waves have equivalent waveform and spectral characteristics to 
those of the electrical driving signal. 
2. Ultrasound propagation through the tissue and coupling with an implant. 
3. Conversion of the acoustic waves back into electrical current. 
4. Rectification and demodulation of the current by the rectifier. 
5. Volume conduction of rectified currents through the tissue. The magnitude and phase 
characteristics of the current depend on tissue impedance. Additionally, the sensitivity of 
the device is greatest in the areas of the highest current density, i.e., in the proximity to 
the device. Volume of the highest sensitivity can be estimated using principles discussed 
in [52]. 
6. Detection of volume conducted current, and extraction of the magnitude and phase 
characteristics of the baseband signal component. 
Additionally, Fig. 7B describes the principle of neural stimulation realized using the same 
type of device. The key difference between impedance measurements and neural stimulation lies 
within the differences of the waveforms used for driving an ultrasound exciter. In the case of 
impedance measurements, this signal is continuous, but in the case of neural stimulation the train 
of pulses is used. Pulse excitation allows boosting of the spatial peak of acoustic power, which 
results in the consequent increase of the generated stimulatory current. Such optimization is 
important due to the existing regulatory limits restricting the acoustic power levels 
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Fig. 7.  Schematic of the principle of wireless impedance measurement technique and neural 
stimulation using acoustically powered devices. (A) Impedance measurement principle, (B) neural 
stimulation principle. Acoustic signals are marked as “US”, electrical signals as “el.” 
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dissipated in the tissue and consequently limiting the maximal achievable current. Overall, this 
form of powering leads to the increased ability of the system in reaching neural stimulation 
threshold, which depends on variety of factors, such as tissue and output port impedance of the 
device, and device position relative to the targeted nerve (e.g., extrafascicular vs. intrafascicular 
stimulation). 
Additional difference between microimplant’s based wireless stimulation and impedance 
recording lies within the role of rectifier. In case of neural stimulation, the role of the rectifier 
involves rectification of the high frequency carrier. This is due to the observation made in our lab 
that nerves do not respond to the high frequency (in our case low-MHz range) alternating 
currents, but instead they respond to the RMS value of rectified monophasic applied stimulus. 
Consequently, the rectifier converts biphasic signal with RMS = 0 into semi or fully rectified signal 
with much higher RMS. In turn, in the case of impedance measurements, the stimulatory effects 
are highly undesirable, but rectifier still plays an important role in signal demodulation, i.e., 
separation of the baseband signal from the carrier. This baseband signal is required for tissue 
interrogation because it lies within the low-kHz frequency range, which corresponds to α and β 
electrical dispersions of biological matter. Without demodulator, tissue would be interrogated only 
by the high frequency carrier and not by the baseband signal. The principles of rectification and 
demodulation will be discussed to the greater extent in the following section on device 
characterization. 
Fig. 7 also introduces the idea of utilization of the surface electrodes used for feedback 
control of neural stimulation and for impedance measurements. In [8-9] authors introduced the 
idea of localization of implanted piezoelectric crystals by measuring the electrical potentials using 
surface electrodes. This proposal involved utilization of the volume conducted fields for estimation 
of the currents generated by the implant. In the ultimate clinical application, current control would 
be very critical because we cannot rely on the “blind” stimulation, having only physiological 
response as a form of feedback. Proposed approach of current estimation relies on the extraction 
of carrier harmonics from the detected volume conducted currents. As it will be discussed later, 
harmonic generation is an intrinsic quality of the rectifiers, which potentially can be useful for 
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separation of the signal produced by the device from initial excitation signals. Initially the idea of 
this form of current control was introduced for microwave powered devices and was 
demonstrated to be feasible through benchtop experiments, but it can become useful also for the 
applications involving ultrasound devices. 
 
System structure and experimental setup 
The basic structure of the system used to perform the majority of experiments within this 
work is shown on Fig. 8A. Specific system components used to execute the experiments are 
shown on Fig. 8B. In majority of experiments, the setup contained a baseband signal generator 
(Stanford Research Systems DS345 30 MHz), carrier signal generator (Philips PM5138), driver 
amplifier (OPHIR GRF 3032), ultrasound transducer (varied for different experiments, both 
 
 
 
Fig. 8.  Block diagram of the impedance measurement system (A) and photograph of the system 
setup (B). In (A) solid arrows denote wired connections, but dashed arrows – wireless coupling 
through the tissue (acoustical (US) or electrical (el.) coupling). 
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commercial and self-made transducers were used; an example of the structure of self-made 
transducer is shown on Fig. 9), sample under 
investigation, acoustically powered microimplant, 
surface electrodes  (Ag/AgCl) and lock-in amplifier 
(Stanford Research Systems SR530). Additionally, 
on the Fig. 8B spectrum analyzer (Hewlett Packard 
ESA-L1500A 9kHz-1.5GHz) and the oscilloscope 
(Tektronix TDS 2024 200 MHz) are shown, which 
were used for the characterization of system 
performance, but are not the essential components of the measurement system. 
Carrier signal generator provides a high frequency sinusoidal signal (in the frequency 
range from 0.5 MHz – 2 MHz, which depends on the resonance frequencies of the ultrasound 
exciter and receiver), required to power ultrasound transducer. Baseband signal generator 
outputs a low frequency (in the range of 10 Hz up to 100 kHz) sinusoidal baseband signal. This 
low frequency signal is used to amplitude modulate (AM) the high frequency carrier, which then 
through the amplifier is applied to the transducer. Amplification is required in order to achieve 
sufficiently high acoustic power output from the ultrasound exciter. For impedance measurements 
typical voltages used to power ultrasound transducers were in the range of 30-60 V. Control of 
this voltage allows control of the current output from the implant, and in addition to the control 
over other waveform parameters, this essentially allows us to switch between stimulation and 
impedance measurement modes of operation of the microdevice. By changing powering 
parameters different stimulation regimens can be achieved – stimulation at nerve motor 
subthreshold or above threshold levels, resulting in such effects as blood perfusion modulation  or 
pain relief and motor response respectively (as discussed in [2]).  
After supplying amplified voltage to the ultrasound transducer, it reproduces the same 
AM modulated signal in acoustic form, which then propagates through the tissue in the form of 
compression-rarefaction wave and couples to the implant. The piezoelectric crystal of the device 
(in our case PZT-5A) then generates an AM modulated waveform in the form of an electrical 
 
Fig. 9.  Structure of the custom-made 
unfocused shielded and grounded 
ultrasound transducer. 
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current, which essentially replicates the external driving waveform (as it could be noted from the 
Fig. 7B, this is not absolutely true in case of the pulsed powering due to the fact that we are 
working with damped ultrasound transducers). Next, the rectifier of the microimplant rectifies 
(demodulates) AM modulated current, causing tissue interrogation by both low frequency 
baseband signal and high frequency carrier (additionally, tissue becomes interrogated by all the 
harmonics produced as result of rectification process). The magnitude of the current passing 
through the tissue depends on tissue impedance. This impedance in turn has a frequency 
dependent nature, which allows spectral characterization of the electrical properties of this tissue. 
In our system this is done by sweeping the baseband signal and making measurements at every 
baseband frequency. The skin potential generated by the device current flow is remotely detected 
via surface bioelectrodes. The amplitude and phase of detected current are recorded as a 
function of ultrasound modulation frequency. In the present work, phase and magnitude (RMS 
value) information were extracted from the detected surface potentials using lock-in amplifier. 
This amplifier is fed with the baseband reference signal, which essentially allows locking into 
specific frequency of interest and extraction of the signal at this frequency even out of the very 
complex and noisy waveform (extracted signals can be on the order of nanovolts).  
It is worth noting that some of the further discussed experiments involved direct wired 
connection of the implant by clip leads to the measurement equipment. Though, in the ultimate 
clinically applicable system such measurements would not involve any wired coupling to the 
device. 
 
Simulations and experiments 
I. System simulations 
Performance of the system involving low-MHz carrier modulation by low-kHz baseband 
signal with consequent signal demodulation using low-threshold voltage diode was analyzed 
using PSpice simulations (PSpice Student Version 9.1 OrCAD Inc.). Layouts of the simulated 
electrical circuits are shown on Fig. 10 and 11.  
  26 
Circuits shown on Fig. 10 were used to analyze the applicability of demodulated AM 
carrier for extraction of the impedance information from the sample. These circuits compare four 
possible scenarios: sample interrogation using the baseband signal applied directly from the 
generator (Fig. 10A), sample interrogation using AM modulated carrier (Fig. 10B), sample 
interrogation using demodulated AM carrier with impedance data extraction at baseband, carrier 
sidebands and carrier harmonic sidebands (Fig. 10C and 10D). Additionally, circuit performance 
 
 
 
Fig. 10.  Layouts of the circuits used for PSpice simulations of impedance analysis of the RC circuit. (A) 
Circuit for impedance measurements using direct output from the baseband signal generator. (B) Circuit 
for impedance measurements using modulated carrier. (C), (D) Circuits with diode in parallel (C) and 
series (D) connection for impedance measurements using demodulated AM carrier. 
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is assessed for two cases involving different diode connection configurations (Fig. 10C and 10D). 
In the circuits shown on Fig. 10B, 10C and 10D, modulation was achieved using 
multiplication of the outputs of two signal generators. 20 pF capacitor in parallel to the generators 
mimics a piezoelectric voltage source, whereas 150 kΩ resistor mimics leakage resistance of the 
piezoelectric crystal. Modulated carrier (1MHz) was then applied through the diode and 1 kΩ 
electrode resistance to the parallel RC circuit mimicking our sample. Resistance value of RC 
circuit has not been changed, whereas capacitance was varied (100 nF to 470 nF) to introduce 
impedance changes. 
Analysis of the effects of diode connection configuration on the system performance 
involved simulations of the diode’s I-V characteristic curves. For this purpose circuits shown on 
Fig. 11 were used, which involved DC voltage application to the diode and consequent current 
measurements across the load. 
In all simulations a CDF7621 (Skyworks, Inc.) Schottky diode was used. This type of 
diode suits well our application. It is characterized by low threshold voltage (270-350 mV at 1 mA) 
and diode die dimensions as low as 0.241 mm x 0.241 mm x 0.165 mm (Package 571-006). 
 
II. System performance characterization 
The typical setup used for the system performance characterization on the benchtop is shown on 
Fig. 12A and 12B. Basically, experiments with the bigger transducers (diameter ≥ 40 mm, as 
shown on Fig. 12A) involved attachment of the water bath to the transducer for acoustic coupling. 
 
Fig. 11.  Layouts of the PSpice circuits used for the analysis of I-V characteristic curves of the diode in 
two different connections. (A) Parallel diode configuration, (B) series diode configuration. 
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Device then could be placed into water bath using the electrical pickups for signal detection and 
for holding the device in place. Alternatively, as it will be discussed later, device could be 
maintained stationary in the water bath using some self-made holders with signal detection using 
the remote electrodes. In addition, in case of the self-made transducers of the type shown on Fig. 
9, instead of attaching the water bath to the transducer, ultrasound coupling gel could be placed 
on top of the face of the transducer to ensure the coupling. For instance, such types of the setups 
were used in order to analyze the dependence of the output voltage of device on load (as shown 
on Fig. 12C; results are shown on Fig. 32 and 33). The same setup shown on Fig. 12C was also 
used to determine the output port impedance of the devices by finding the resistive load, which 
causes output voltage drop by a half. 
The same setups were also used to obtain waveforms and spectra shown on Fig. 31, 
having water bath filled with the saline solution of conductivity equivalent to the muscle tissue 
(880 µS/cm). The device response shown on Fig. 30 was obtained using the same principle as 
shown on Fig. 12, but instead of the two generators and amplifier to drive the transducer, the 
pulser/receiver (Computer controlled pulser/receiver, Model 5800, Parametrics, Inc.) was used. 
 
Fig. 12.  Photographs and schematic of the device and transducer testing setups. (A) Example of the 
testing involving big diameter (38 mm) focused transducer. (B) Example of the testing involving small (20 
mm) unfocused self-made transducer. (C) Example of setup for estimation of the implant output port 
impedance and its behavior with different loads. 
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Results presented on Fig. 27B were obtained using the setup similar to the setup shown on Fig. 
12A, only instead of the pickups, Ag/AgCl electrodes were used for wireless detection. In turn, 
plot of the phase and RMS variation with time for the bridge based device shown on Fig. 28B was 
obtained from the device placed in the cadaveric rat following the principles discussed in the 
further chapters on tissue sample interrogation experiments. 
Furthermore, the dependence of the wirelessly detected output voltage on the distance 
between the device and the electrodes was analyzed using the setup sketched on Fig. 13. For 
these measurements solution with conductivity of 1950 µS/cm was used. Focused commercial 
transducer (Ø40 mm, Panametrics, Inc.) driven at the carrier of 1.4 MHz modulated by 1 kHz was 
immersed into water tank. The acoustic power density in the focus used for this experiment was ~ 
43 mW/cm2, which is more than 15 times smaller than approved FDA limit. Such low level 
acoustic power was used to prevent overdrive and consequent overheating of the driving 
amplifier and transducer itself, as well as to reduce the problems with crosstalk.  
It must be noted that in all cases of wireless measurements signals were measured using 
the lock-in amplifier, whereas in cases of the measurements done using the pickups signals were 
typically analyzed using the oscilloscope. If not stated otherwise, all plots in the Results section 
having RMS voltages on the ordinate axis, are based on the measurements done using the lock-
in amplifier, whereas the peak-to-peak (Pk-Pk) voltages were measured using the oscilloscope.  
FDA limits for the ultrasound are defined as acoustic power density, but when we are 
driving the ultrasound transducer the only known parameter is the driving voltage used to power 
 
Fig. 13.  Schematic of the experiment for the analysis of wirelessly measured output voltage 
dependence on the distance between the electrodes and device. 
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the transducer. Therefore, to be able to compare the acoustic energies used in the experiments 
to FDA limits it was necessary to convert driving voltages into acoustic power density. This was 
achieved using the electrobalance method shown on Fig. 14A, which involves measurements of 
the ultrasound pressure. For these measurements water bath with highly absorbent material at 
the bottom was used. The cup with absorber and solution was placed on the highly sensitive 
scales (METTLER AE240, sensitivity = 0.1 mg). Face of the transducer stably fixed by the holder 
was immersed into water bath. Before starting the measurements, the setup was left at least for 
30 minutes to let it settle down and prevent any drift during measurements. Next, for every given 
driving voltage the apparent mass increase was recorded. Obtained mass was converted into 
acoustic power using the following equation: 
 =
∆∙∙
	

        (1) 
where Δm is the deviated weight caused by the radiation force, g is the gravity, c is velocity of 
ultrasound waves in water and R is the reflection coefficient of the target. In our case, the target is 
made out of sponge and is considered to be 100% absorptive, resulting in R = 0. 
To translate acoustic power into acoustic power density, in case of the focused 
transducer the acoustic power was divided by the size of the focal spot, whereas for the 
 
Fig. 14.  Photographs of the acoustic power output measurements. (A) Acoustic radiation force caused 
weight deviation measurements using electrobalance. (B) Measurement of the focal spot size for 
focused transducer. 
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unfocused transducer the acoustic power was divided by the surface area of the face of the 
transducer itself. In order to determine the size of the focal spot, the setup shown on Fig. 14B 
was used. The acoustic probe made of PZT-5A with dimensions of 1.016 mm x 0.102 mm x 0.635 
mm was moved around the acoustic field of the transducer and peak-to-peak voltages were 
recorded from the scope. The focal spot is defined as the area of full width half maximum, i.e., the 
area in which transducer output is within the half of the peak output. For the commercial focused 
transducer shown on Fig. 12A and 14, used to perform the majority of measurements, the focal 
spot was estimated to be 0.38 mm2 by examining the plot of the output voltages from the acoustic 
probe.  Acoustic power density dependence on the driving voltage for two of the transducers used 
within present study is shown on Fig. 27A. 
Consequently, using the setup shown on Fig. 12A and 12B, the dependence of the 
wirelessly detected output voltage on the estimated acoustic power density was determined 
(results shown on Fig. 27B). 
 
III. Wired characterization of RC circuits 
First experiment involving impedance measurements was basically equivalent to the 
PSpice simulation involving parallel diode configuration with interrogation of the RC circuit (Fig. 
10C). In the experiment shown on Fig. 15A, three different capacitance values were used: 100 
nF, 220 nF, 470 nF (the same as in the simulations). In this experiment the Schottky based 
device was placed on top of distilled water bath (with conductivity of 5 µS/cm) to provide acoustic 
coupling of ultrasound transducer with the implant. Electrodes of the device were covered with 
clay for the isolation to prevent loading of the device by solution. 
Experiment also involved several additional conditions. The output of the device was also 
recorded in the case of absence of the capacitor, allowing analysis of the device performance at 
different baseband frequencies just with the resistive load. As it is discussed in the conference 
proceeding [59] written based on some of the results presented here, one of the experiments 
involved interrogation of RC circuit having 10 kΩ in series with the device. This was done to make 
the device act as a constant current source instead of the constant voltage source (as in 
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case of the layout shown on Fig. 15A). Constant current sources are often used in conventional 
impedance measurements to limit the current and prevent any damage caused to the tissue 
under investigation. These experiments involved the baseband frequency sweeping and 
consequent phase and voltage RMS recording at different frequencies. 
An additional experiment shown on Fig. 15B was done to investigate impedance 
measurement approach involving detection of the carrier sideband signals. This approach was 
also tested using simulations and will be discussed in the Simulations Discussion section. In the 
experiment the detection was achieved using radio receiver (WinRadio G305e). Measured 
signals were fed into computer, which allowed data analysis using LabView SignalExpress by 
creating a WinRadio virtual sound card. Further, impedance spectra were recorded by looking at 
the magnitude of the baseband signal in FFT spectra. The input stage of the radio receiver 
incorporated 910 kΩ resistance to prevent overloading of the receiver. Basically, with such input 
resistance only very small fraction of the signal could pass through and the bulk of the signal 
could be radio-transmitted from the device to the receiver. Presence of the wired connection 
essentially ensured stable coupling of the radio receiver to the signal source between the trials, 
eliminating any extra variability associated with slight deviations of antenna placement relative to 
the source. 
 
Fig. 15.  Schematics of the RC circuit impedance wired measurement experiments. (A) Measurements 
using lock-in amplifier, (B) measurements using radio-receiver. 
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IV. Wired and wireless characterization of saline solutions 
In the transition process from the experiments involving absolutely non biological 
samples (e.g., RC circuits) to the experiments utilizing actual tissue samples and ultimately the 
live subjects, system ability to detect impedance changes was tested by performing the 
experiments with saline solutions. The solutions were made by adding salt to distilled water. 
Conductivities were chosen to be equivalent to conductivities of different tissue types.  
The experiment shown on Fig. 16A was done using the solutions with conductivities of 
2.5, 335, 1800 and 4400 µS/cm. For the experiment shown on Fig. 16B the solutions with 
conductivities of 170, 1300, 2000, 2200 µS/cm have been used. Consequently, in the first case 
measurements were done by having the clip-leads attached to the device, whereas in the second 
case measurements were done totally wirelessly using the Ag/AgCl electrodes immersed into 
solution. As in this case the solutions themselves have been used as the samples under 
investigation, the device was fully immersed into solutions (in contrast to the experiments with RC 
circuits, where device with isolated electrodes was placed just on the surface of the solution 
without touching the solution). 
 
 
 
Fig. 16.  Schematics of the saline solution interrogation experiments. (A) Wired measurements with 
signal measurements using clip leads, (B) wireless measurements using Ag/AgCl electrodes. 
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V. Wired and wireless characterization of tissue samples 
Next set of experiments was done with tissue samples, involving measurements using 
slices of beef stacked into water bath and measurements using devices placed into cadaveric 
rats. For wired and wireless impedance measurements of beef samples the setup shown on Fig. 
17A was used. The only difference in case of the wired measurements involved attachment of the 
clip-leads to the device for signal detection instead of the Ag/AgCl electrodes used for wireless 
signal detection (as shown on Fig. 17A). In both cases the implant was placed on top of the stack 
of beef (40 mm high) with its electrodes inserted into meat sample and device body having good 
contact with meat surface to ensure acoustic coupling. In case of the remote signal detection, the 
output of the implant was detected using Ag/AgCl surface electrodes, placed at the same height 
as implant’s electrodes and 15 mm away from the implant’s electrodes in the horizontal plane. In 
both cases of wired and wireless measurements the impedance changes were induced by adding 
drops (~ 0.1 ml) of saline solution (~ 1500 µS/cm) to the sample.  
In case of the experiment shown on Fig. 17B, which involved device placement into 
cadaveric rat’s muscle pocket of the lower limb in vicinity of femoral artery (approximately the 
same location where it was placed in the live rat in this study and in [2]), the impedance changes 
were induced by injecting (~0.1 ml) the saline solution (~1500 µS/cm) into the area around the 
device. 
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Fig. 17.  Schematics of the wireless impedance measurement experiments of tissue samples. (A) 
Experiment with device placed on top of the stacked beef, involving induction of the impedance changes 
by adding the drops of saline solution. (B) Experiment with device placed into muscle pocket in the lower 
limb of cadaveric rat. Impedance changes were induced through injection of saline solution (in both 
experiments 0.1 ml, 1500 µS/cm). 
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VI. Live animal experiments 
The bridge rectifier based device was implanted into female Sprague Dawley rat (mass 
289 g., DOB 03.18.2014) on May 8, 2014. The device was implanted into the lower left limb in the 
muscle pocket in vicinity to femoral artery. The pocket between the muscles was entered in the 
location shown on Fig. 18A and device was pushed down into pocket along a femoral artery. It 
was attempted to place the device as low as possible in the limb. This was done because, as it 
will be discussed later, the planned live animal experiment involved occlusion of the femoral 
artery at the base of the limb (in the region of hip joint) to cause the reactive hyperaemia, 
detectable using the laser Doppler flowmeter. 
The surgery was approximately an hour long; rat was anesthetized using the isoflurane. 
After the surgery, having the rat placed back into cage, rat removed the simple-interrupted 
braided suture within approximately an hour, leading to the repeated suturing of the wound using 
the intradermal pattern. Rat was further left for 5 days to heal and within these days rat was 
administered with subcutaneous injections of the following drugs: Baytril, Buprenorphine, 
Meloxicam (detailed information can be found on the approved protocol #1270). 
The implanted device was of the type shown on Fig. 6B. The device was 6 mm long and 
3 mm in diameter (1.8 mm long electrodes with diameter of 0.5 mm; the dimensions of the used 
PZT-5A are 1.6 mm x 1.0 mm x 0.8 mm). 
Five days after the implantation the experiment similar to what is shown on Fig. 19A was 
 
 
Fig. 18.  Photographs of the live rat during the experiments. (A) Post-surgical photograph of the incision 
site, (B) photograph of the impedance measurement experiment. 
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performed aiming at identifying if the implant can be excited and produce signals detectable from 
the surface of the skin. The first trials of the experiment, in contrast to that is shown on Fig. 19A, 
involved measurements done using just a pair of the electrodes and ungrounded highly-focused 
commercial transducer (Ø38 mm). Commercial transducers are characterized by much better 
shielding than our custom-made transducers and consequently weaker crosstalk. Therefore, 
transducer could be driven using maximally achievable voltages – 60 V, which produced 315 
mW/cm2 of acoustic power density in the focal spot. During this experiment the lower limbs of the 
rat were restrained using the surgical tape, as well as the Ag/AgCl electrodes were secured to 
remain stationary by fixating them using the tape. Rat was held under the isoflurane for a whole 
duration of each experiment. The photograph of the typical trial showing the transducer and 
electrode placement is shown on Fig. 18B. 
The trials performed at later stages of this work were done following the measurement 
principles shown on Fig. 19. Fig. 19A shows the idea behind the differential impedance 
measurement experiments, whereas Fig. 19B shows the principle of the shock excitation of the 
implant, which provides higher spatial peak power. Basically, the system shown on Fig. 19A 
incorporates such additional components as extra electrode, as well as shielding and grounding 
of the self-made transducer (Fig. 9). All of these measures were gradually introduced to reduce 
the level of crosstalk, which showed to be a mild problem during the experiments with cadaveric 
rats and were observed to be magnified during the first trials with a live rat. Additionally, the 
transducer has shown to play an important role, therefore in the latter trials six different 
transducers have been tested (4 commercial and 2 self-made ones), mainly having different 
focusing, shielding, bandwidth and resonant frequencies.  
The measurement system shown on Fig. 19B did not involve differential measurements 
using three electrodes because the time delay between the interference and actual signal was 
providing the immunity against crosstalk. Moreover, in this case the ultrasound pulser/receiver 
was not only used to drive the transducer with 180 V, but also to detect the signals from the 
device, providing 60 dB gain for detected signals. 
All animal experiments were approved by institutional IACUC. 
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Fig. 19.  Schematics of the live rat experiments. (A) Schematic of the impedance measurement 
experiment, (B) schematic of the experiment testing the magnitude of the wirelessly detected signal 
produced by the tone burst excitation. 
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CHAPTER 4 
RESULTS 
I. System simulations 
As result of the simulations based on the circuits shown on Fig. 10 and 11, the plots 
shown on Fig. 20 through 26 have been obtained. 
Plots shown on Fig. 20 and 21 demonstrate the shapes of the waveforms and spectra of 
the voltages produced by the circuits shown on Fig. 10C and 10D, respectively. The purpose of 
the analysis of these circuits involves identification of the best diode configuration (although, 
potentially other types of rectifiers could be used) in the implants, allowing most efficient 
 
 
 
 
Fig. 20.  Waveforms and Fourier spectra of the rectified AM voltage produced in the case of parallel 
diode configuration (Fig. 10C). (A) 10 Hz baseband with 0.5 V drive, (B) 10 kHz baseband with 0.5 V 
drive, (C) 10 Hz baseband with 3 V drive, (D) 10 kHz baseband with 3 V drive. 
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impedance measurements and neurostimulation. The key further addressed features of these 
waveforms and spectra include: the level of rectification, presence or absence of DC offset, 
harmonic production in the spectral domain, level of the carrier versus baseband signal, and 
diode performance dependence on the driving voltage. 
Fig. 22 shows the I-V characteristic curves for the Schottky diodes for the circuits shown 
on Fig. 11. These curves were obtained for three different loads and they provide further insights 
into circuit behavior with two different diode configurations. 
Next, Fig. 23 and 24 provide actual RC circuit interrogation results for four circuits shown 
on Fig. 10. These results are shown in the form of frequency spectra of the output voltages 
 
 
 
 
Fig. 21.  Waveforms and Fourier spectra of the rectified AM voltage produced in the case of diode 
connection in series (Fig. 10D). (A) 10 Hz baseband with 0.05 V drive, (B) 10 kHz baseband with 0.05 V 
drive, (C) 10 Hz baseband with 0.5 V drive, (D) 10 kHz baseband with 0.5 V drive, (E) 10 Hz baseband 
with 3 V drive, (F) 10 kHz baseband with 3 V drive. 
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across the RC circuit for the frequency range between 10 Hz and 50 kHz (this frequency range 
follows from the frequencies achievable using our experimental setup). Output voltages were 
obtained at the baseband frequencies from the Fourier spectra (as shown on Fig. 20 and 21). In 
reality, the harmonic frequencies of the baseband were used for getting these plots, as will be 
discussed further in the discussion section, because as it can be seen from the spectra on Fig. 20 
and 21, the actual baseband signals were not present after the demodulation. Instead, only the 
harmonics were present with the main power at double-baseband frequency. For all the plots on 
Fig. 23 output voltages were maintained to be 2 V across the piezoelectric voltage source (20 pF 
capacitor) by adjusting driving voltages for every circuit configuration. 
 
 
Fig. 22.  I-V characteristic curves of the Schottky diode in two different configurations for three different 
loads – 1 kΩ, 5 kΩ and 10 kΩ. (A) Parallel diode connection (Fig. 10C), (B) diode connection in series 
(Fig. 10D). 
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Fig. 23.  Impedance analysis plots from PSpice simulations based on the circuits shown on Fig. 10A, 
10C and 10D. (A) Comparison of the three interrogation cases: using demodulated AM voltage for series 
diode configuration (Fig. 10D), using demodulated AM voltage for parallel diode configuration (Fig. 10C), 
and using baseband voltage directly from the generator (Fig. 10A). (B) Comparison of the RC circuit 
characterizing curves obtained using AM demodulated voltage from parallel configuration and direct 
circuit interrogation using the baseband generator. (C) RC circuit impedance spectra obtained using 2nd 
harmonic produced by the diode. In (A) and (B) solid lines denote RC circuit with C = 470 nF, in (B) and 
(C) dashed lines denote RC circuit with C = 100 nF, in (B) dotted lines denote RC circuit with C = 220 
nF. 
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Fig. 23A provides voltage spectra comparison of the three circuit layouts shown on Fig. 
10A, 10C and 10D for the RC circuit with capacitance of 470 nF. Fig. 23B provides RC circuit 
interrogation results for the circuits shown on Fig. 10A and 10C with capacitance values of 100 
nF, 220 nF and 470 nF. Fig. 23C shows voltage spectra obtained using demodulated carrier from 
two different diode configurations as before, only in this case a second harmonic of the baseband 
signal was used (3x frequency of the baseband). This was done to identify whether one of the 
configurations allows sample interrogation using simultaneously multiple frequencies having  
 
 
Fig. 24.  RC circuit impedance plots resulting from interrogations using AM modulated carrier without 
demodulation (based on the circuit shown on Fig. 10B). Orange traces correspond to the signal value at 
baseband frequency, purple – at carrier sideband frequency (FCARRIER + FBASEBAND). 
 
 
Fig. 25.  Fourier spectra of the carrier and carrier harmonic frequency ranges (modulation at 10 Hz). 
Carrier frequency for parallel (A1) and series (B1) diode configuration, carrier harmonics for parallel (A2) 
and series (B2) configuration. 
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harmonic relationships. These harmonics represent the bi-product of the process of demodulation 
and it would be beneficial not to waste this power, and use it to interrogate the sample 
simultaneously at multiple frequencies, as will be discussed further. 
Furthermore, Fig. 24 presents the results of the RC circuit interrogation using AM 
modulated carrier without demodulation (based on the circuit shown on Fig. 10B). 
Finally, Fig. 25 presents the high frequency-range spectra for two diode configurations. 
Fig. 25 includes spectra of the both sidebands of the carrier itself, as well as spectra showing the 
harmonics of the carrier with sidebands of the doubled baseband frequency. 
The spectral components shown at Fig. 25 were used to produce impedance spectra 
shown on Fig. 24 and 26. As will be discussed later, this type of analysis was done in order to 
investigate the potential of impedance data collection using the radio receiver with antenna, 
instead of the surface electrodes. These spectra were made by using voltage magnitude values 
from Fourier spectra obtained for different modulation frequencies. The following spectral 
components have been investigated (Fig. 26A1 and 26B1): 
• peaks at frequencies fcarrier -/+ fbaseband; 
• peaks at frequencies 2fcarrier -/+ 2fbaseband; 
• peak at harmonic frequency 2fcarrier. 
After identifying the spectral component exhibiting the trend characteristic for impedance 
frequency dependent nature, specific spectral components were selected to investigate their 
sensitivity to impedance changes (Fig. 26A2 and 26B2). Impedance changes were made the 
same way as before, by changing the capacitance value of the RC circuit.  
To obtain Fourier spectra and impedance spectra shown on Fig. 24, 25 and 26, 
respectively, the circuits shown on Fig. 10B, 10C and 10D have been used. 
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Fig. 26.  RC circuit voltage spectra obtained using carrier and harmonic sidebands. (A) Parallel diode 
configuration, (B) series diode configuration. (1) Measurements done using carrier and carrier harmonic 
sidebands and harmonic fundamental, (2) measurements using higher frequency sideband of the carrier 
(FCARRIER + FBASEBAND). 
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II. System performance characterization 
Based on the principles discussed in the Methods section, plots of the acoustic power 
density dependence on driving voltage and of the wirelessly detected voltage RMS on acoustic 
power density were obtained for two different transducers (Fig. 27). For device output voltage 
measurements (Fig. 27B) the bridge based device has been used. 
Next, device output variability was assessed in case of the wired (Fig. 28A) and wireless 
(Fig. 28B) detection. In case of wired detection, the data have been recorded at two different 
 
 
 
Fig. 27.  Plots demonstrating acoustic power density dependence on the driving voltage (A) and device 
output voltage RMS dependence on acoustic power density (B). 
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carrier frequencies with the acoustic power density ~98 mW/cm2. In case of wireless detection, 
phase and RMS variations were analyzed at two different baseband frequencies at the acoustic 
power density ~133 mW/cm2. In this case the maximal possible drive voltage for a given setup 
was used (~60 V on the self-made transducer). Additionally, cadaveric rat experiment involved 
two trials performed on different days, where in the second trial the transducer was better fixed 
relative to the rat to prevent any drift of the transducer over time.  For both experiments with 
results shown on Fig. 28 the bridge based device has been used. 
 
 
 
 
Fig. 28.  Device output variability characterization. (A) Plot of variation of the peak-to-peak device output 
voltage with time at two different carrier frequencies (wired detection). (B) Plot of the phase and RMS 
variations with time at different baseband frequencies (wireless detection). 
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Furthermore, Fig. 29 shows average results of the three trials for the dependence of the 
wirelessly detected output voltage RMS on the distance between the device and the electrodes.  
Additionally, the device response to the shock pulse excitation is demonstrated on Fig. 
30. This is similar type of excitation used to drive the device for the neurostimulation applications. 
Fig. 30 shows both actual driving pulse (Fig. 30A), as well as typical device response waveform 
to the applied excitation (Fig. 30B). 
Further, the waveforms and spectra of the output voltage for different types of devices 
are shown on Fig. 31. This data has been obtained for the simple PZT without the rectifier (Fig. 
 
Fig. 29.  Wirelessly detected device output voltage RMS dependence on the distance between the 
electrodes and device (device driven by 43 mW/cm2 in the solution with conductivity 1950 µS/cm). 
 
Fig. 30.  Device driving using tone burst excitation. (A) Pulse train used for the excitation (peak-to-peak 
voltage ~ 180 V), (B) Excitation sync pulse (yellow) and device response (cyan). 
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31A), for the Schottky based device (Fig. 31B), for the bridge based device (Fig. 31C) and 
varicap diode based device (Fig. 31D). Spectra are shown both for the carrier frequency region 
(B) and baseband frequency region (B). For these experiments 850 kHz carrier and 1 kHz 
baseband signal has been used used. In order to maximally mimic the physiological conditions, 
 
 
 
 
Fig. 31.  Photos of the waveforms and Fourier spectra for different types of devices loaded by the 
solution with conductivity of 880 µS/cm (driven by 43 mW/cm2 with 850 kHz carrier and 1 kHz 
baseband). (A) PZT-5A without the rectifier, (B) Schottky based device, (C) bridge full-wave rectifier 
based device, (D) varicap diode based device. 
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the coupling solution with the conductivity from the muscle tissue range has been used to load 
the devices.  
In addition, device output voltage dependence on the load was measured for all three 
types of devices with devices placed on top of the column of distilled water to prevent loading of 
the device. Resistive loads were connected in parallel to the devices. Knowing the peak output 
 
 
Fig. 32.  Device output voltage dependence on the resistive load (wired detection; acoustic power 
density ≈ 24 mW/cm2). 
 
 
Fig. 33.  Bridge full-wave rectifier based device output waveform dependence on the load. (A) Loaded by 
distilled solution (high load), (B) Load ≈ 300 Ω, (C) Load ≈ 1300 Ω, (D) Load ≈ 3300 Ω. 
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voltages for every device without any loading attached, Fig. 32 allows estimation of the output 
port impedances of the given devices. For unloaded Schottky device peak output was 1.52 V, for 
bridge rectifier device – 2.14 V and for varicap diode device – 1.34 V. 
Finally, the changes of waveforms with the load for different devices have been 
investigated and Fig. 33 demonstrates such results only for the bridge based device. 
 
III. Wired characterization of RC circuits 
The results for the experiments involving wired interrogation of RC circuits are shown on 
Fig. 34, 35 and 36. Fig. 34 presents the results for the RC circuit interrogation using the implant 
as constant current source (RC circuit has 10 kΩ resistor in series). Spectra for five different 
cases are presented – four different capacitance values and circuit without the capacitance. 
Additionally, to be able to assess the accuracy of obtained spectra, the time constant values are 
marked on the spectra (as 70.7% of the RMS value at 10 Hz).  
 
 
Fig. 34.  Voltage RMS spectra for RC circuit with 10 kΩ series resistor (acoustic power density 43 
mW/cm2; wired measurements). 
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Fig. 35.  Phase and voltage RMS spectra for RC circuit experiment (acoustic power density 43 mW/cm2; 
wired measurements). (A1) Voltage RMS full spectra for frequency range 10 Hz – 70 kHz, (A2) the same 
spectra as in (A1) without the higher frequency part (voltages for RC circuit without capacitance on the 
right Y axis). (B) Phase spectra. 
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Fig. 35 demonstrates similar results only for the case where neurostimulator is assumed 
to be the constant voltage source. Fig. 35A1 shows voltage RMS full spectra for all recorded 
frequencies from 10 Hz to 70 kHz, whereas Fig. 35A2 shows the lower frequency portion of the 
spectra making possible the analysis of the changes occurring at low frequencies. Additionally, 
spectra shown on Fig 35A2 have the theoretically estimated and experimentally determined time 
constants marked on the plots. Fig. 35B shows the phase spectra for the same 4 layouts of RC 
circuit. 
Finally, the results of the RC circuit interrogation experiment using radio receiver are 
shown on Fig. 36, which shows voltage spectra (up to 5 kHz) for RC circuits with four different 
capacitance values. The signals of sub millivolt amplitudes shown on Fig. 36 have been detected 
with device placed on top of the distilled water bath (device output was on the order of 1.5 V). 
 
IV. Wired and wireless characterization of saline solutions 
The results of the experiments involving wired and wireless interrogation of the saline 
solutions with different conductivities are shown on Fig. 37. In case of wired measurements, (Fig. 
37A) both phase and magnitude have been recorded at four different baseband frequencies. In 
case of wireless measurements, only magnitude has been recorded, but measurements for every 
 
Fig. 36.  RC circuit voltage spectra obtained using radio receiver (acoustic power density 43 mW/cm2; 
wired measurements through 910 kΩ). 
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frequency-conductivity pair have been repeated 25 times to be able to account better for the 
previously discussed measurement fluctuations characteristic for our system.  
 
V. Wired and wireless characterization of tissue samples 
Fig. 38A shows the results of the experiment involving wired characterization of the beef 
tissue samples with voltage RMS and phase spectra for baseband frequency range of 10 Hz – 7 
kHz. Fig. 38B demonstrates the results of the experiment with the same setup, but using remote 
signal detection. 
 
 
Fig. 37.  Results of the wired (A) and wireless (B) characterization of different saline solutions. Solid 
lines denote voltage RMS, dashed lines – phase. 
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Furthermore, Fig. 39 demonstrates the results of the two experiments done with device 
placed into cadaveric rat. The main difference between these two trials done with cadaveric rat is 
in the number of baseband frequencies used to record the data, which mainly affects the duration 
of the experiment. Taking into account previously discussed fluctuations of the signal over time, 
recording duration appeared to be really important in this experiment. Therefore, the second trial 
 
 
Fig. 38.  Wired (A) and wireless (B) magnitude and phase spectra for beef tissue samples (the acoustic 
power density for wired measurements ~ 40 mW/cm2, but for wireless measurements ~ 315 mW/cm2). 
Solid lines denote voltage RMS, dashed lines – phase. 
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(Fig. 39B) involved recording of the much fewer number of frequencies as the measure of 
optimization for these fluctuations. 
 
VI. Live animal experiments 
As it was discussed in the Methods section, several trials were made in the attempt of 
getting wireless impedance data from live rat. The first trials involved utilization of highly focused 
 
 
Fig. 39.  Phase and voltage RMS spectra for two experiments with device placed into lower limb of the 
cadaveric rat. Impedance changes have been induced by injection of the saline solutions. Acoustic 
power density ~133 mW/cm2. Solid lines denote voltage RMS, dashed lines – phase. 
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(focus diameter ~ 7 mm) commercial ungrounded transducer with acoustic power of 315 
mW/cm2. After many attempts as high as 3.3 mV output signal from the device could be 
wirelessly detected using the surface electrodes and measured with the lock-in amplifier. This 
signal though was very unstable and the baseline could not be established, which is necessary to 
be able to do the impedance measurements at multiple frequencies. The details of encountered 
difficulties will be discussed in the Discussion section.  
Following first set of unsuccessful trials rat remained unperturbed for the summer period 
and next set of trials were done only after 5 months since the implantation (performed using the 
setup shown on Fig. 19A). The improvements made prior to the new set of trials mainly were 
aiming at elimination of the crosstalk problem. These improvements mainly involved construction 
of the new ultrasound transducers (in accordance with structure shown on Fig. 9), as well as 
introduction of the differential measurement method. Despite the improved measurement setup, 
baseline could not be established. 
These unsuccessful trials have been followed by the measurements performed in 
accordance with the principles illustrated on Fig. 19B, involving the burst excitation of the device. 
This approach allowed detection of the output of the device, which is shown on Fig. 40. Signal 
shown on Fig. 40 is the result of the 60 dB amplification performed by the pulser/receiver, which 
gives the peak-to-peak magnitude of the signal shown on Fig. 40B to be around 2 mV. 
 
Fig. 40.  Photographs of the wirelessly detected responses from the burst excited device implanted in 
the live rat. (A) Excitation was done using commercial focused transducer, (B) using self-made 
unfocused transducer. 
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It was important to know whether utilized burst excitation provides sufficient power in 
accordance with FDA limits and whether power can be increased even further to produce 
stronger signals. The problem was that previously described method, involving measurements 
with electrobalance, requires the transducer to be driven using continuous waveform drive, which 
is not the case with tone burst excitation. Therefore, in order to estimate the acoustic power, 
additional benchtop measurements have been performed. These measurements involved 
placement of the device, having very similar characteristics as the one implanted in the rat, in the 
acoustic beam in the way it is shown on Fig. 12B. The device was first driven using the tone burst 
excitation, producing 1 V. Next, device was driven using the continuous waveform with drive 
voltage adjusted in order to achieve the same level of electrical output as in case of the burst 
excitation. The approximated power density was concluded to be approximately 35 mW/cm2. The 
only limitation of this estimation is that determined acoustic power is more indicative of the 
average power provided by burst excitation, whereas more interesting would be to determine the 
peak power density (in case of the pulsed excitation, the peak electrical output is mostly defined 
by the applied spatial peak temporal peak power, but in case of the continuous drive by the 
spatial peak temporal average power).  
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CHAPTER 5 
DISCUSSION 
I. System simulations 
Baseband frequency range spectral components. Plots shown on the Fig. 20 and 21 led 
to the several important observations. One of them follows from the spectra and involves the fact 
that demodulation produces the baseband signal of the two fold greater frequency than that is 
produced by the baseband generator. As it was shown in the Results section of System 
performance characterization, such behavior was not observed on the benchtop. Due to the fact 
that on the benchtop given specific Schottky diode has not been used, it is possible that this is 
exactly the way how this type of the diode behaves in real life, but it is also possible that this 
behavior is just the result of the intrinsic imperfections of the model itself. Still, it must be noted 
that if this behavior is the case in real world, then it should not have any negative effects on the 
system performance both in case of neurostimulation and impedance recording. In fact, such 
behavior can be even beneficial due to the higher interference resistance. Basically, with such 
behavior of the system we would become shielded against the interference between driving 
signal and actual output of the device. With our setup such interference was present due to the 
signal leakage out of the transducer through the sample to the surface electrodes (capacitive 
coupling), as well as RF (inductive) coupling between the driven transducer and input stage of the 
detector (lock-in amplifier). The consequence of this is the fact that noise level at the baseband 
frequency was always higher than at harmonic frequencies. Of course, noise can be dealt with 
using sophisticated shielding and good grounding, but harmonic utilization for the measurements 
is much easier approach allowing reduction of the hardware sophistication. 
Additionally, as it can be seen from the spectra, demodulation process also results in the 
generation of the higher order harmonics, which was also observed during benchtop testing. 
Presence of these harmonics brings additional potential benefit in the form of increased speed of 
the sample interrogation by applying simultaneously multiple signals of different frequencies and 
recording responses at all of these frequencies. Of course, as it is done with the conventional 
impedance measurements, we always can apply complex signal (or even white noise) to begin 
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with and record full spectrum just from the sample response to this single interrogation signal. 
The complication here is the fact that we are dealing with really weak signals. As it will be 
discussed further, the highest signal detected from the live rat was 3.3 mV, meaning that the 
signal at the harmonic would be below 2 mV (this is an example of the exceptionally good 
coupling of the highly focused transducer with the implant; on average detected signals were on 
the order of hundreds of µV and smaller). Basically, the more frequency components we 
incorporate into interrogating signal, the weaker is spectral power of each component. Therefore, 
it is really the question of optimization how many frequencies we can simultaneously apply to the 
sample and still be able to detect signals at each of these frequencies. 
In our case, harmonics are always present in case of the demodulation and therefore 
power is always dissipated, and it makes sense to try to actually utilize this wasted power as 
much as possible. This is exactly the reason why it was attempted to measure RC circuit spectral 
response using second harmonic signal. This attempt resulted in the plot shown on Fig. 23C, 
which is discussed below. 
Presence of DC offset. Next observation from Fig. 20 and 21 is presence of the 
frequency and drive dependent DC offset, which is especially evident in the case of the series 
diode configuration. As it can be seen from the spectra both on Fig. 20 and 21, DC offset 
corresponds to the peak at zero frequency, which in some cases has stronger spectral power 
than the actual baseband (e.g., Fig. 20C2, 20D2 and 21D2). Just as stated before, this leads to 
the power dissipation and weakening of the signal of interest. As it can be seen from Fig. 21B, 
21D1 and 21F, DC offset has time dependent nature. Therefore, by driving the implant using 
pulsed carrier the DC offset should not present any problems, because any weak DC offset 
formed during the drive phase would decay when the pulse is turned off. 
As it will be discussed further, potentially impedance could be measured also using pulse 
excitation in contrast to the continuous drive utilized within present work, which would lead to the 
elimination of the DC offset. Additionally, DC offset can be dealt with by incorporating a capacitor 
into microdevices, but the problem with this approach lies in the introduction of the higher 
complexity into device construction and more importantly increase in the device dimensions. This 
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follows from the fact that in order to allow passage of the baseband signal at least at the 
frequency of 100 Hz, we would need a capacitor with capacitance of 10 µF (assuming the output 
port impedance of the device to be around 1 kΩ). Therefore, the most straightforward approach of 
reduction of the DC offset is utilization of the device construction with the parallel diode 
configuration. 
Diode behavior dependence on the drive. The next observation involves dependence of 
the level of rectification and overall diode behavior on the magnitude of the driving voltage. In the 
case of the parallel diode connection, diode starts to provide sufficiently high rectification only at 
the driving voltage several times greater than the actual diode threshold. Moreover, at the driving 
voltage level tenfold greater than the diode’s threshold the level of rectification with parallel diode 
configuration is much lower than the level of rectification with the series diode connection driven 
by the voltage tenfold smaller than the diode’s threshold. This is really important, because for 
neurostimulation and impedance measurement applications we would not want the diode to 
dictate the level of the power we need to deliver to the device, we want this to be defined only by 
the threshold level of neural activation and minimal detectable impedance signal still carrying all 
required information, respectively. 
Therefore, the behavior of the diode was further analyzed by looking at the I-V 
characteristic curves for the diodes (Fig. 22) based on the circuits shown on Fig. 11. From these 
characteristic curves it can be seen that in case of the diode connection in series, given Schottky 
diode behaves basically as an ideal diode up until -3 V, i.e., the diode resistance in reverse bias 
is almost infinite up until -3 V, which exactly corresponds to the reverse breakdown voltage of the 
used Schottky diode (CDF7621). In case of the parallel diode configuration, diode conducts in 
both directions at all applied voltages. In this configuration conduction is still greater in the 
forward direction, but the difference in conducted currents becomes sufficiently high only after 
reaching voltage levels on the order of several volts. This is exactly the voltage at which 
rectification was observed in our simulations (Fig. 20). Additionally, the I-V curves were obtained 
for the different diode loads, but no significant differences in the behavior of the diode were 
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observed with the changes in the load, as well as with the changes of source output port 
impedance (results are not shown). 
Diode performance dependence on the driving voltage leads to the important conclusion 
that in the application involving limited voltage supply the diode connection in series might be 
more beneficial. In case of our microimplants, voltages above 5 V can be easily achieved on the 
benchtop, but it have not been estimated how high voltages across the device can be achieved in 
the device implanted in the living subject. Still, the physiological responses, obtained from the live 
rats as result of the stimulation produced by our implants with the diode in parallel configuration, 
demonstrate that produced voltages are sufficient to cause rectification and neurostimulation. The 
problem is though that those results were obtained using the devices with 1 mm thick 
piezoelectric crystals in them, but for the actual clinical applications such dimensions are a bit on 
the higher end and we would like to reduce the dimensions down to the 100 µm as discussed in 
[10] and [11]. With such dimensions achieved voltages can be on the order of magnitude lower 
than that is achieved with mm size devices and in such cases the diode connection in series can 
become more favorable than the parallel configuration. 
Additional benefit of the series connection also follows from the observation that it 
basically stops rectifying after reaching certain voltages above 3 V, which would naturally restrict 
the rectification of applied voltages preventing us from the overdriving the nerves. For the ultimate 
clinically applicable product such protective control measure would be absolutely crucial in order 
to obtain an FDA approval. 
Finally, there is an additional clearly practical benefit of having the diode in series 
configuration. Diode connection in series significantly simplifies the construction process of the 
microimplants by requiring connection only of the one diode’s pin to the piezoelectric crystal, 
whereas parallel connection may require incorporation of the additional wire as is shown on Fig. 
6A-2. This becomes even more important when we go down to the smaller dimensions and 
instead of the packaged rectifiers, used in the present work, utilize the unpackaged die-rectifiers. 
It must be noted that all previous work on ultrasonically powered devices has been done 
using the parallel diode configuration. The reason for that follows from the observations of the 
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one of the students that this configurations leads to the more efficient performance of the 
implants, but these observations have not been reported, and any quantitative comparison and 
analysis have not been performed yet. 
RC circuit impedance measurements. Further discussion addresses the results of the RC 
circuit interrogation using circuits shown on Fig. 10, resulting in the plots shown on Fig. 23, 24 
and 26. 
Baseband signal based measurements. Fig. 23A shows the results of the RC circuit 
interrogation by demodulated AM carrier by the diode in two different configurations, as well as 
circuit interrogation using the output directly from the baseband signal generator. The hypothesis 
was that sample interrogation using demodulated AM carrier should yield essentially the same 
spectra as sample interrogation using just the baseband generator. 
Such approach of impedance measurements relying on the carrier modulation and 
consequent sample interrogation using demodulated carrier have not been found anywhere in the 
literature. Therefore it was essential to demonstrate that this is actually possible. Sample 
interrogation using just the single generator is essentially the way how this is done in 
conventional impedance measurements, involving sample electrical impedance spectrum 
recording by applying one frequency of the interest at the time. In case of the utilization of the 
high frequency AM carrier, the assumption is that after demodulation sample is interrogated using 
the baseband signal essentially the same way as it is done in the absence of any carrier. 
Consequently, as it can be seen from Fig. 23A, all three plots demonstrate the RC circuit 
voltage spectra similar to that would be expected from the theoretical point of view, but the plot 
obtained using AM carrier demodulated by the diode connected in parallel to the source leads to 
the spectral response, which follows circuit spectral response to the generator excitation much 
closely than the spectral response obtained in case of the diode connection in series. 
Discrepancies in both cases can be associated with the different contributions of the circuit 
loading produced by the diode itself. Used Schottky diode has a Johnson’s capacitance of 0.10 
pF (at 0 V) and maximal resistance in forward direction of 20 Ω (at 10 mA). Basically, diode is an 
RC circuit itself and it could be expected that it can distort the actual sample response, because 
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we are not looking just at the sample response, but at the combinational response of the diode 
and the sample. Still, as such distortion would be intrinsic quality of the device, it easily could be 
accounted and calibrated for in real clinical application. 
Following better performance demonstrated by the parallel diode configuration, next it 
was demonstrated how closely RC circuit spectral response to the demodulated AM carrier 
follows circuit response to the direct interrogation by the generator in cases of the different 
sample capacitances (100 nF, 220 nF and 470 nF). As it can be seen from Fig. 23B, in all three 
cases sample spectral responses to the demodulated AM carrier exhibit similar trends to those of 
the sample response to direct interrogation (e.g., in both cases with decrease in the capacitance 
the time constant becomes smaller). 
Next, as it was discussed before, it was attempted to obtain the RC circuit response 
using the second harmonic of the baseband signal. As it can be seen from the Fig. 23C, the plot 
obtained using the circuit with parallel diode configuration demonstrates the reverse trend 
compared to the expected behavior. Just the fact that this trend is reverse does not imply that 
harmonic does not carry any impedance information. The only concern is related to the fact that 
as the baseband is swept, the magnitude changes at the harmonic are much smaller than 
changes occurring at baseband frequency. In turn, the spectrum obtained from the series diode 
configuration exhibits signal growth starting from about 7 kHz, similarly as what is observed for 
baseband signal. This shows that potentially some information about sample impedance could be 
extracted using the harmonics in case of the parallel diode configuration, but it would require 
detailed investigation of the trends of impedance plots to be able to account and calibrate for all 
fluctuations of the signal. 
Further, in order to demonstrate that in case of the utilization of AM carrier the 
demodulation achieved by the rectifier is really necessary, voltage spectra were recorded for the 
sample interrogation using the AM carrier without demodulation (based on the circuit shown on 
Fig. 10B). Resulting spectra are shown on Fig. 24 and as it was predicted they do not seem to 
carry any information about the sample under investigation. Basically, recorded voltages were 
recorded on the level of system noise, which is simulated in PSpice to make simulations more 
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realistic. The carrier sidebands though seem to depend on the sample impedance even without 
incorporating the demodulator into circuit, but voltage differences are at sub-millivolt level, making 
detection of such changes exceptionally challenging. The benefits and challenges associated with 
impedance measurements using carrier signal are addressed in the following sections. 
Carrier frequency range spectral components. Circuit behavior has been investigated in 
the carrier frequency region. Fig. 25 shows the Fourier spectra of the absent carrier with 
sidebands and of the carrier harmonics with sidebands. The absence of the carrier have not been 
observed during the benchtop testing, but again just as before the reasons for this could be either 
some unrealistic behavior of the model or more probably this is actually the real behavior of the 
Schottky diode used in the simulations, which has not been tested on the benchtop. 
The absence of the carrier should not have any effects on the performance of the system 
investigated in this work, which relies on the detection of demodulated baseband frequency 
volume conducted currents. Still, such behavior would be greatly beneficial for briefly addressed 
measurement method relying on the signal detection using radio receiver with antenna. 
Encountered problems associated with radio receiver based detection will be discussed in the 
section on RC circuit characterization, but the principle is that the carrier emitted from the 
ultrasound exciter (not the actual microdevice) interferes with radio receiver. Certain techniques 
might be utilized to eliminate such interference, but having a rectifier with such characteristics as 
what is observed during the simulations would eliminate this requirement for any further system 
sophistication. Basically, all the spectral components shown on Fig. 25 are products of the action 
of the diode, and therefore potentially all of these components can be used for wireless 
measurements using radio receiver. 
Carrier signal based measurements. Consequently, Fig. 26 shows the results of 
simulation targeting the assessment of the feasibility of wireless impedance measurements using 
the antenna and radio receiver. The main benefit of this approach is that measurements would 
become absolutely wireless, eliminating the requirement for having detecting electrodes coupled 
with the surface of the skin. This could simplify the measurement process for the ultimate user. 
Additionally, getting rid of the electrodes eliminates the effects of the electrodes on measurement 
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performance (e.g., changes in electrode coupling with the skin, temperature induced changes of 
the electrodes). The main question which the results shown on Fig. 26 are trying to answer is if 
any impedance related changes even occur in the carrier frequency region. Furthermore, 
additional question is actually related to the spectral component, which would provide the highest 
measurement sensitivity. 
Just as before, the analysis of the high frequency components was done for two circuit 
configurations and Fourier spectra for both configurations (Fig. 25) exhibit very similar 
characteristics. The only exception is that the series diode configuration showed to produce 
stronger higher order sidebands, which ultimately could be used as additional impedance 
information carriers. 
Trying to identify the spectral components providing highest sensitivity, all five main 
spectral components were used at the beginning (Fig. 26A1 and 26A2). Components exhibiting 
the gradually changing magnitude with baseband frequency sweep have been chosen to perform 
the RC circuit analysis. Fig. 26A2 and 26B2 clearly show that despite the opposite changes with 
frequencies, both diode configurations provide full ability to differentiate between different 
impedances. Although the parallel diode configuration provides more typical impedance behavior 
with frequency, if the series configuration would have any additional benefits, we could easily 
account for the opposite trend of frequency dependence (magnitude increase with frequency 
versus decrease with frequency). It is important to take into account how big are signal changes 
with impedance in case when measurements are done using baseband signal and using the 
carrier-frequency range signals. By looking at results from Fig. 23 and Fig. 26, if capacitance is 
changed from 470 nF to 100 nF then the magnitude changes, for example, at 1 kHz are the 
following: 
• doubled baseband (2 kHz) signal with series configuration – 29.5%; 
• carrier sideband (1 MHz + 1 kHz) signal with series configuration – 0.06%; 
• doubled baseband (2 kHz) signal with parallel configuration – 22.6%; 
• carrier sideband (1 MHz + 1 kHz) signal with parallel configuration – 1.6%. 
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These values clearly illustrate that the highest sensitivity can be achieved by measuring 
the baseband frequency range signals and this sensitivity drops more than by the order of 
magnitude if we move to the carrier frequency range. Still, it is possible that some circuit 
alterations can improve system sensitivity and radio receiving based impedance measurement 
method demonstrates the potential for being useful. 
Summarizing points. Some of the conclusions of the simulation experiments are: 
• based on the fact that parallel diode configuration demonstrated ability of characterizing 
the sample impedance in more similar way to sample characterization using just the 
baseband generator, much stronger baseband signal with this configuration, as well as 
taking into account the fact that all work previously done in our lab involved devices 
constructed with parallel diode configuration, for the present study only devices with 
parallel Schottky diode-to-source configuration have been used (as well as devices with 
bridge full-wave rectifier and varicap diodes); 
• further reduction of the implant dimensions would require maximal optimization of the 
system, which would also require quantitative benchtop testing of the performance of 
devices with different diode configurations; 
• RC circuit impedance characterization proved to be possible using carrier sideband 
signals, but further system improvements might be required to improve measurement 
sensitivity. 
 
II. System performance characterization 
Acoustic power dependence on the drive. From the results presented on Fig. 27A it can 
be seen that, just as it was expected, there is square law relationship between the transducer 
driving voltage and the acoustic power density produced by this transducer. It can be seen that 
the highest acoustic power density achieved with the used setup being driven by continuous 
waveform is still more than two fold smaller than the FDA approved safety limit for the spatial 
peak temporal average power density. In every instance when specific acoustic power density 
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used in the experiment is mentioned in this work, it follows from the results presented on the Fig. 
27A. 
Fig. 27B demonstrates the dependence of the wirelessly detected output voltage RMS on 
the acoustic power density or essentially the driving voltage of the transducer. Again, as it could 
be expected, this relationship is fairly linear. It demonstrates our good ability to control the actual 
currents delivered to the nerves by controlling the acoustic power applied to the implant. 
Analysis of signal variability. Results shown on Fig. 28 give insights into instabilities 
associated with our devices. Of course, the time duration investigated in the experiment, which 
produced the results shown on Fig. 28A and involved wired signal detection directly from the 
device, is a bit to the higher end than what would be used in real life for impedance 
measurements. Still, the additional clinical application of the devices discussed within present 
work is pain relief, which might require as long stimulation times as 10 minutes. In the case of 
wired detection after 10 minutes, the output voltage of the device dropped by about 7%. 
Additionally, with stimulators presently available on the market for pain relief, patients actually 
have an option of leaving them on for all the time and often times this preference is dictated by 
the patient readiness to tolerate the buzzing sensation instead of the pain. Furthermore, it must 
be emphasized that in both experiments producing the results shown on Fig. 28 the device was 
remained absolutely undisturbed and firmly fixed in the focus of the transducer. This would not be 
the case with the patients and actual clinical applications, because no matter how well you would 
fix the external exciter, the relative motion of the exciter and implant still will be present, 
especially if we are talking about the applications on the extremities. This fact highlights the 
importance of the continuous feedback for the stimulation applications, which will be reinforced 
later in the discussion. This feedback would allow continuous adjustment of both the beam focus 
and driving voltage, ensuring the stable output of the stimulatory currents. 
In case of the wireless detection from the cadaveric rat (results on Fig. 28B), variability of 
the output RMS is even higher than in case of the wired detection. The highest observed change 
of 80% was observed after 10 minutes during the trial #2 with 1 kHz baseband signal. This can be 
associated with the fact that we moved to the more realistic testing setup, in which the relative 
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positioning of the device and transducer cannot be controlled so well as during the experiments 
with saline solutions. There is a number of factors which can contribute to such variations of 
output:  
• changes in the coupling between the transducer and device (despite all the attempts to 
prevent motion of the system components, some microdrift still could be present); 
• the heating of the sample (although, in this cases care has been taken to prevent 
overdriving of the transducer, causing the heating of the transducer itself, which then can 
be transferred to the sample; additionally, despite the fact that some time was spent 
letting the cadaveric rat body to warm up after getting it out of the fridge, some internal 
temperature fluctuations still could be present; heating caused by the ultrasound itself is 
not considered here due to the low power density levels utilized to perform the 
experiments); 
• the fluctuations (including temperature induced ones) in the equipment used to drive the 
transducer; 
• variations in the sample or device electrode impedance (this definitely was the case in 
the experiment involving wired output detection, because the hydrolysis of the water 
around the device electrodes could be observed; this is also related to the previous 
discussion of temperature changes). Impedance variations is the most probable 
contributor to observed changes mainly due to the fact that it was attempted to eliminate 
and account for all other factors, but it is difficult to account for impedance variations due 
to the changing nature of the impedance. Therefore, it can be argued that this experiment 
demonstrates the impedance sensitive behavior of the microdevices. 
The notion of hydrolysis leads to the important problem of charge balancing, which would 
need to be dealt with before our devices can become clinically applicable. The most 
straightforward solution involves incorporation of the charge-balancing capacitor into the device, 
which must be selected carefully to prevent significant increase in the dimensions of the devices, 
as well as retain the ability of tissue interrogation at very low baseband frequencies. 
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Additional observation from Fig. 28A is the fact that the carrier frequency producing 
weaker output also results in the lower fluctuations of the output over time. This was often 
observed during the experiments performed in the process of this work, where reduction in the 
output voltages of the devices was also typically associated with less distorted waveforms than 
that was observed in the cases of higher outputs (results not presented). 
Moreover, from Fig. 28B it can be noted that overall the variations of the phase over time 
are weaker than variations of RMS values (except the trial #2 at 1 kHz, for which both RMS and 
phase exhibited significant changes). This observation can suggest that the main cause for the 
fluctuations lies in the impedance changes of the device electrodes or the sample, because as it 
could be noted from [50] the highest phase changes occur in the high frequency region (with peak 
around 90 kHz), whereas the magnitude sensitivity to the changes starts to roll off exactly around 
the 100 kHz. If this assumption of the reasoning for output fluctuations is correct, then it provides 
the first insights into very high sensitivity of these microdevices to the impedance changes 
(although of course it is not known how close are all the impedance changes occurring during 
these experiments to the actual impedance changes associated with the physiological events). 
Final remark about the results of the output variability over time emphasizes the 
importance of these results for all the rest of the experiments performed within this work. As it can 
be seen from Fig. 28B, basically obtained curves for a single frequency have very similar trends 
to the actual impedance spectra and precautions must be taken to prevent misinterpreting the 
data and accepting the spectral plots demonstrating the falling trend as the real impedance 
characteristic curve. It can resemble a problem especially in some experiments lasting for tens of 
minutes due to the lack of the recording automatization (all the numbers were typically recorded 
by hand), as well as additional time required for the lock-in amplifier to lock into new baseband 
frequency (required time depends on the selected time constant defining the range around the 
baseband frequency we lock into). As the matter of precaution, many measurements, results for 
which are shown within this work, involved continuous referral to one specific frequency to make 
sure that the output at this reference frequency have not change during the time while data was 
collected for the other frequencies (for example, experiment can start by looking into voltage at 1 
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kHz, then data can be collected for 5 other frequencies and 1 kHz frequency is checked again. 
This pattern repeats after looking into each set of 5 different frequencies). For example, in case of 
the experiment aiming at the analysis of waveform characteristics, as well as device output 
dependence on the load (results shown on Fig. 31, 32 and 33), the “cheating” approach was 
used. It was desired to maintain the outputs at the same level throughout the experiment, but too 
significant output fluctuations were observed (on the order of 10% within 1-2 minutes). Therefore, 
for many measurements the position of the device relative to the transducer was continuously 
adjusted (typically by ~ 1 mm in X, Y or Z direction) to maintain the output stable. 
Volume conducted electrical response detectability dependence on the distance. Fig. 29 
presents the results of the assessment of signal detectability depending on the distance between 
the implant and detection electrodes. Of course, the applicability of these results is fairly limited 
because measurements have been done in the water bath, offering us full control over the 
acoustic coupling between the implant and transducer (e.g., with such setups in cases of too low 
output it typically can be easily corrected by rotating the device, whereas with live subjects such 
control measures are much more restricted). Still, it can be seen that even in the case of good 
acoustic coupling between highly focused transducer and device, the detected output voltages at 
baseband frequencies are on the order of sub-millivolts (in reality detected voltages were much 
higher due to the crosstalk between the transducer and detection electrodes resulting in the 0.29 
mV of background noise, which was subtracted from all measurements before plotting them). 
Despite fairly weak signal, it still was detectable up to 36 mm. Taking into account that in reality 
applied acoustic power could be increased by more than 15 times, as well as with live subject 
electrode-device relative positions could be better suited for more efficient detection (as it can be 
seen from Fig. 13, the detection electrodes were oriented perpendicularly to the device 
electrodes, which is not perfect orientation in case of the detection at long distances, it is perfect 
orientation only at 0 mm distance when the electrodes are on the same line with the electrodes), 
the maximal achievable distance still allowing detection should be easily increased even further. 
Still, even the depth on the order of 36 mm is fairly close to that is required for the applications in 
PVD (as it was stated in [2], the sciatic nerve in humans in lower limb is 50 mm or less away from 
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the surface). Finally, this was the first experiment where the crosstalk between the transducer 
and electrodes started to be considered. 
Burst pulse excitation. Fig. 30A presents the tone burst pulse train. This excitation pattern 
can be used for neurostimulation in a similar way as it is shown on Fig. 7B (as well as on Fig. 
19B). Fig. 30B illustrates the response of the bridge device to such type of excitation. The 
response waveform detected using the wired pickups clearly exhibits the ring-up and ring-down 
phases, with the ring-down phase longer than the ring-up phase, which is defined by the quality 
factor of the receiver. In this case, the ring-down of the device is fairly short, indicating that the 
piezoelectric receiver in the implant is highly damped by the solution and epoxy. Fig. 30B also 
illustrates the important benefit of the pulse excitation versus the excitation using the continuous 
waveform. In case of the pulsed excitation there is a transient time delay between the excitation 
induced crosstalk and the actual response of the implant. This is caused by the fact that it takes 
much less time for the electrical signal to pass to the detection electrodes (or in this case the 
wired pickups) than what it takes for the acoustic waves to reach the implant, perform 
piezoelectric conversion and reach the detector. This driving modality allows clear separation 
between device output and excitation artifact, making it very desirable to use similar type of 
pulsed excitation also for the impedance measurements. 
Characterization of different device types. Fig. 31 demonstrates a set of waveforms and 
spectra of these waveforms, produced by the different types of devices, being loaded in the 
similar way to that we expect them to be loaded while being implanted in tissue.  
Piezoelectric material without rectifier. Fig. 31A illustrates the case of simple piezoelectric 
material (PZT-5A) without any rectifier attached. Just as it would be expected, on the spectra we 
can see the carrier (without sidebands due to the low modulation frequency of just 1 kHz and 
broad frequency span of 5 MHz) and no signs of baseband. There are some fairly strong peaks in 
the baseband frequency region, but they probably are caused by the system imperfections. As 
these artefacts are not present at the same frequencies for other types of devices, they must be 
caused by the piezoelectric material itself, probably due to the fact that piezoelectric material 
does not perfectly recreate the supplied driving waveform. One of the reasons for that is the fact 
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that the water bath used to obtain these waveforms (Fig. 12A) contains a lot of reflections, 
meaning that the piezoelectric receiver actually receives the more complex waveform than what 
is produced by the exciting transducer. This fact could be easily confirmed by observing how the 
waveform changes while the device is moved around the ultrasound beam. For instance, the level 
of modulation could change from 100% down to 50% simply by moving the device by several 
millimeters. Fortunately, this is just the imperfection of the used setup, which we must be aware 
of, but in the tissue we would not have such reflection problems. 
Schottky diode based device. Fig. 31B 
presents the waveform and spectra obtained for 
the Schottky diode based device with the parallel 
diode configuration. This time spectra show not 
only the carrier at 850 kHz, but also the 
demodulated baseband signal at 1 kHz, as well as 
the harmonic at 2 kHz. Baseband frequency region 
also contains a lot of the other spectral components, which represent the natural artifacts caused 
by both the reflections discussed above and the actual rectification produced by the diode 
(rectification deform the waveform and we cannot expect it to contain just the carrier and 
baseband with harmonics). All these additional spectral components basically dissipate the 
power, leading to the weaker baseband signal of interest. Therefore, we would like to achieve as 
perfect rectification as possible. The ideal half-wave rectified waveform what we would like to 
obtain using Schottky based device is shown on Fig. 41. It must be noted that even the 
waveforms obtained using the PSpice simulations (Fig. 20) did not exhibit perfect rectification; 
instead waveforms observed during the simulations fairly closely repeat the waveforms observed 
in the experiments. Furthermore, the level of rectification achieved using the Schottky diode is 
significantly dependent on the load. The most perfect rectification maximally close to what is 
shown on Fig. 41 was observed for the devices placed into distilled water without any load 
attached (results are not shown, but the level of rectification is very similar to the shown on Fig. 
33B). 
 
Fig. 41.  Half-wave and full-wave rectified 
sinusoidal signal in case of the ideal 
rectification. 
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Bridge full-wave rectifying device. Fig. 31C presents the waveforms and spectra obtained 
for the full-wave rectifying bridge based device. In this case the high frequency portion of the 
spectrum contains not only the carrier, but also the harmonics of the carrier, which as it was 
discussed in the simulations section, potentially can carry the impedance information in its side-
bands and be detectable using the radio receiver. The baseband frequency region in this case 
also contains much greater number of harmonics (at least three harmonics are present). As it can 
be seen from the actual waveform, the level of rectification in this case is much higher than in 
case of the single Schottky diode. This was absolutely expected, because we basically have four 
Schottky diodes instead of the single one. Therefore, the strength and number of harmonics 
potentially can be associated with the strength of the signal produced by the device and the level 
of rectification. This correlates with the observations previously done, but never reported by 
another student in our lab, who proposed to use the surface electrodes detected harmonics for 
the estimation of device output in the tissue. 
Additionally, from the spectrum on Fig. 31C3 it can be noted that the strength of the 
artefacts is much weaker than what was observed for the simple piece of PZT or Schottky based 
device, which again can be linked to the better rectification achieved by bridge full-wave rectifier. 
Moreover, by comparing the simulations results (Fig. 20 and 21) with the results obtained from 
benchtop testing of the bridge device (Fig. 31C), it can be noted that the waveform produced in 
case of the full-wave bridge rectification, is very similar to that was observed for the series diode 
configuration. There is even more important similarity between the simulation results for the 
series diode configuration and experimental results for the bridge devices. In both cases fairly 
good rectification was still present even at voltages significantly below the threshold, which is 
especially surprising for the bridge diode, because taking into account the fact that bridge rectifier 
contains actually several diodes instead of the single one, it would be expected to be required to 
reach higher voltages to get any rectification. Such behavior was observed both for the bridge 
devices with attached resistive load and devices loaded only by the solution. Even at voltages 
below 200 mV the bridge was providing much higher rectification than the single Schottky, which 
at such voltage barely provides any rectification at all. 
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Fig. 33 demonstrates the waveforms produced by the bridge based device at various 
loads. The load of 300 Ω drops the voltage below 200 mV, but rectification remains almost 100%. 
It was also observed that by dropping the voltage down to 50 mV by adding the 56 Ω resistive 
load, the level of rectification still remains almost 100%, with slight deformation of the waveform 
(results are not shown). Overall, before performing any experiments the full-wave bridge rectifier 
was considered the perfect choice offering the best rectification characteristics, having the main 
disadvantage of much higher dimensions, as well as higher construction complexity and expected 
higher threshold. After performed testing, additional benefit of the full-wave bridge rectifier was 
observed in the form of its good rectification characteristics even at the voltages below its 
threshold. Still, the dimensions remain serious problem and taking into account similarities 
between the behavior of the single Schottky diode in series configuration observed in the 
simulations and benchtop testing results for the bridge devices, it would be useful to look both 
into benchtop behavior of the series diode configuration and behavior of the full-wave bridge 
rectifier in the simulations. 
Varicap diode based device. Fig. 31D demonstrates the rectification performance of the 
varicap diode based device. As it can be seen the varactor diode demonstrates weaker 
rectification than the Schottky diode, the same spectral content in the baseband frequency region 
and for unclear reasons slightly noisier carrier frequency region. Potentially the varicap diode with 
better rectification characteristics could be found, but even observed level of rectification 
demonstrates the potential for varactor based device to incorporate triple functionality – neural 
recording, neurostimulation and impedance measurements. The idea of neural recording using 
varicap based devices relies on the capacitance dependence of the varactor on applied bias. 
Therefore, the capacitance of the varactor should depend on the presence or absence of the 
neural spikes. Changes in capacitance cause the changes in the tuning of the device. 
Consequently, such device can be shock excited by tone burst with consequent recording of its 
decaying response. Depending on the tuning of the device, this decaying response will change, 
i.e., number of ring-down pulses will vary depending on the presence or absence of neural 
activity. During this work only the RF powered varactor devices have been tested with minimal 
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detected signal of 5 mV (results not shown), which potentially could be reduced even lower by 
eliminating all the sources of noise and improving the detection methods (e.g., using highly tuned 
antenna with radio-receiver). 
Alternatively, varactor based devices could be used to convert the amplitude and phase 
carrying impedance signal into-ring down signal, which is more desirable due to the amplitude 
dependence on many different factors (e.g., surface electrode coupling with the skin, relative 
position of the surface electrodes, implant and ultrasound exciter coupling). Basically, the perfect 
system would involve excitation of the varactor based implant using chopped AM carrier, which 
generates tissue interrogating currents passing around the device. These currents would change 
the capacitance of the device itself in accordance to their amplitude, which is again dependent on 
tissue impedance. Then the next excitation wave comes in only in the form of tone burst. The 
resulting ring-down signal then would be dependent on the currents produced by the device itself, 
which in turn are dependent on tissue impedance. Ultimately, the ring-down signal now would 
contain the impedance information and this signal would be immune to the factors affecting 
measurements of the AM signals. The key difficulty would be to make such recordings possible 
using the single one device, but having two devices placed relatively close together (e.g., one 
with simple Schottky and another varicap based) would make such measurements much easier, 
but introduction of simultaneously multiple devices would be acceptable only if they can be made 
sufficiently small, preventing undesirable damage of the tissue. 
Device performance with loading. In addition to the previously discussed waveform 
changes associated with device loading (Fig. 33), the actual dependence of the device output 
peak-to-peak voltage on the resistive load was investigated with the results shown on Fig. 32. For 
the Schottky and bridge based device the relationship is fairly linear. For the Schottky and 
varactor based devices the curves exhibit the breaking points around the output port impedance 
of the devices (both for varactor and Schottky based devices it was estimated to be around 1 kΩ), 
but for the full-wave rectifying device the output port impedance was estimated to be around 3.3 
kΩ (the breaking point for the bridge device is not shown because the highest resistive load used 
in the experiment was 3.3 kΩ). The importance of the output port impedance follows from the fact 
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that it defines the load a specific device is capable to drive and we would like to have the output 
port impedance of the device to be as close as possible to the tissue (load) impedance, because 
although voltage is shown to be increasing with the increase in resistive load, what we are 
interested in is actually the power produced by the device. Therefore, despite the fact that we 
would like our devices to be as simple as possible, if there would be a really significant benefit of 
having higher load on the device, it is possible to incorporate the resistor into device. 
Summary on system performance characterization. Some key observations, findings and 
conclusions of this section on System performance characterization are the following: 
• the acoustic power density produced by the ultrasound transducer exponentially depends 
on the transducer driving voltage; 
• the relationship between the acoustic power density and device output voltage is almost 
linear; 
• device output measured on the benchtop exhibited significant (as high as 80% within 10 
minutes) fluctuations over time. These fluctuations arguably can be considered 
associated with impedance changes and must be mainly taken into account while 
performing measurements using given specific setup utilized in this work; 
• even at acoustic power densities more than 15 times smaller than approved FDA limit, 
the signal from the device is still detectable as far as 36 mm in homogenous media made 
of saline solution; 
• device pulsed excitation is associated with additional benefits both for the stimulation and 
monitoring applications – it allows achieving higher spatial peak powers while maintaining 
the same level of temporal average power and it allows separation of the crosstalk and 
actual signal of interest; 
• the full wave bridge rectifier provides the best rectification characteristics, whereas the 
varactor diodes – poorest rectification; 
• varicap diode based device exhibit the potential for triple functionality – neural recording, 
neurostimulation and impedance monitoring; 
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• full bridge rectifier demonstrates the performance similar to that was observed during the 
simulations of the circuit with single diode series connection configuration. Taking into 
account benefits associated with usage of the single diode, diode series configuration 
would need to be further investigated; 
• the output port impedance and impedance of the tissue the device will be implanted to 
must be carefully considered to ensure their approximate equivalence for maximally 
efficient power delivery to the tissue. 
 
III. Wired characterization of RC circuits 
RC circuit characterization using constant current source. Voltage RMS spectra shown 
on Fig. 34 demonstrate the ability of the neurostimulator to interrogate RC circuits in case of the 
wired signal detection and constant current source. As criterion of accuracy the cut-off frequency 
was used. The device allowed estimation of the cut-off frequencies with the maximum error of 
6.1%. Additional important observation is the stability of the device output in case when it is 
loaded only with resistive load. The maximal change of the voltage RMS across the frequencies 
is 4%, which can be associated with previously discussed naturally occurring output fluctuations 
over time. This implies that device the capacitance of the device itself (the electrodes, the PZT, 
the diode) do not have significant contribution to the load created by the sample. 
RC circuit characterization using constant voltage source. Fig. 35 demonstrates the 
voltage RMS and phase spectra for the case when device is assumed to be the constant voltage 
source. Just as before, device clearly demonstrates the ability to differentiate between different 
RC circuits, as well as obtain the spectral characteristics of the circuits. In this case the maximal 
error for the estimation of cut-off frequency was on the order of 5% (the fact that the 
measurements are done starting not from the 0 Hz, but from the 10 Hz, makes slight contribution 
to this error). In this experiment in the case of absence of the capacitor in RC circuit the voltage 
RMS exhibited as high as 15% drop. Still, as this happens only when we go to the frequencies 
above 50 kHz, this must be associated with the limited bandwidth of the transducer. No matter 
how broad bandwidth the transducer has, as the driving frequency moves away from the central 
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frequency the transducer is tuned to, the output of the transducer will gradually roll off. In our 
case, the carrier remains unchanged having the same frequency maximally close to the 
frequency the transducer is tuned to, but the modulation caused sidebands move further away 
from the carrier as we sweep the baseband frequency. Therefore, as these sidebands move 
further away, the acoustic output of the transducer at these sideband frequencies (carrier 
frequency +/- baseband frequency) also decreases, leading to the decreased electrical response 
of the implant at these frequencies. We are essentially measuring the output of the device at 
demodulated sidebands and if device response to these sideband frequencies decreases, our 
readings at demodulated baseband frequencies will also change. 
As PZT in the implant is also essentially the ultrasound transducer, it’s tuning curve also 
have a bell shape and essentially its output can roll off as the excitation frequency moves away 
from the frequency the PZT is tuned to. Basically, the limited baseband of the piezoelectrics in 
exciter and receiver limits the frequency range we can work with. In the case of the used exciter-
receiver (transducer-device) combination this range is essentially limited to about 10 kHz, which 
can be absolutely sufficient for the magnitude measurements of the impedance, because above 
this frequency theory predicts mainly phase changes with low magnitude sensitivity to 
physiological events. 
Additionally, we could argue that knowing specific baseband characteristics of the 
piezoelectrics being used, we can account and calibrate for these changes. Of course, in such 
case for effective calibration it would be necessary to account for the fact that device will be 
damped by the tissue, which actually should make the baseband of the device only broader.  
Finally, it also must be noted that in the experiments it was observed that piezoelectrics 
also exhibit harmonic behavior, i.e., the output is highest at certain resonance frequency of the 
transducer and at harmonics of this frequency. As efficiency of the device drive and therefore the 
output of the piezoelectric depends on the coupling between exciter and receiver, it could be 
observed that depending on the receiver position in the beam, the highest electrical output will be 
obtained at different carrier frequencies. For instance, in some cases the highest output could be 
obtained just as expected at the resonance frequency of the transducer, but after moving the 
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receiver into slightly different position the peak output could move actually to the harmonic 
frequency. 
In case of the phase, it can be seen that significant changes occur in case of the absence 
of capacitor in the circuit, but still by looking at the phase spectra, different RC circuits can be 
easily differentiated. 
RC circuit characterization using radio receiver based detection. Finally, a number of 
unsuccessful trials have been made to obtain impedance spectra for RC circuits using radio 
receiver for signal detection. From Fig. 36 it can be noted that, just as in the case of simulations, 
the carrier sideband signals measured using radio receiver exhibit the typical falling trend 
expected for frequency dependent impedance, but signal contains too many fluctuations to be 
able to differentiate between different RC circuits. The key problem identified in the process of 
measurements was associated with used radio receiver. WinRadio G305e incorporates such 
function as automatic gain control, which provides stable demodulated signal (stable sound) 
despite any variations in the amplitudes of the sidebands. In our case we are specifically 
interested in the changes in amplitudes of the sidebands, because these changes are associated 
with impedance changes. From Fig. 36 it can be clearly seen that the falling trends of voltage 
spectra contain many jumps in magnitude, which can be associated with automatic gain control 
trying to maintain the stable level of decreasing sideband magnitudes. Being unable to switch off 
the automatic gain control, chosen radio receiver cannot be used for such types of 
measurements. 
Additional difficulty was associated with differentiation between the signal from the device 
and crosstalk. In this context the best performance was observed in case of the full-bridge 
rectifier based devices, which produce strong carrier harmonics. The crosstalk level at the carrier 
is much stronger because the transducer is driven by high voltage at carrier frequency, whereas 
the crosstalk at carrier harmonic frequency is associated only with imperfections of the used 
amplifier driving the transducer. The harmonics produced by the driving amplifier could be filtered 
out, allowing detection of the clean harmonic using radio receiver. 
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The problem is of course that in the simulations the Schottky diode connected in parallel 
showed weak system sensitivity with carrier harmonic and harmonic sidebands. Simulations also 
demonstrated the ability of the Schottky diode to eliminate the carrier. The same elimination could 
also be attempted to achieve by feeding the carrier reference into radio receiver and subtracting it 
from the carrier measured from the device. Finally, it must be noted that during performed 
experiment the unturned antenna has been used to determine that the output of the device 
generating 1.5 V could be still detected as far as 120 mm away (mainly by listening to the sound 
produced from demodulated sidebands), providing µV level signal. This demonstrates high 
sensitivity of radio receiver based approach, but in a real situation having the microdevice 
implanted in the body such distances would probably not be achievable. 
Summarizing points. The main observations made from the RC circuit analysis 
experiment can be summarized in the following points: 
• acoustically powered neurostimulator demonstrates the same ability to perform 
impedance spectral characterization of the RC circuit as the circuits simulated in PSpice, 
meaning that if impedance characterization will show to be not possible at further stages 
of the work, this must be associated with the limitations introduced by wireless detection; 
• both magnitude and phase spectral curves obtained using neurostimulator demonstrate 
the trends predicted by theory; 
• neurostimulator showed to be able to differentiate between different RC circuits both by 
phase and magnitude; 
• the capacitance of the neurostimulator itself does not have significant contribution to the 
sample under investigation, leading to the stable device voltage output under resistive 
load; 
• it has been shown that the neurostimulator based constant current source does not have 
advantages over constant voltage source. Whereas the benefits of having a constant 
voltage source include the more simple device construction (no need in resistor) and 
higher currents delivered to the tissue; 
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• impedance measurements using a radio receiver for wireless signal detection have been 
shown to be potentially feasible, but further investigation is required using radio receiver 
without automatic gain control, as well as additional measures for carrier crosstalk 
suppression must be employed; 
• the bandwidth characteristics of the piezoelectric exciter and receiver must be taken into 
account when analyzing the spectral response of the sample. 
 
IV. Wired and wireless characterization of saline solutions 
Wired characterization of saline solutions. In case of the wired measurements (Fig. 37A) 
it can be seen that device can easily differentiate between the solutions of different conductivities 
using the magnitude information, whereas phase has shown to allow differentiation between 
different conductivities, but results are not consistent. The magnitude measurements showed the 
ability of differentiation at all 4 analyzed frequencies, having the expected falling trend with 
increase in the conductivity of the sample, as well as voltage undergoes a decline with an 
increase in baseband frequency. This trend of frequency dependence is broken if we look at the 
results at 5 kHz and 10 kHz, because voltages at 10 kHz were slightly higher than at 5 kHz, but 
overall they are very similar just as would be expected. Based on the previously mentioned theory 
and shown results, as the frequency goes up impedance magnitude differences for different 
samples become really small. In case of the phase, at 0.1 kHz and 1 kHz the trend was that 
phase was increasing with increase in conductivity, whereas at 5 kHz and 10 kHz this trend was 
broken and less consistent dependence can be observed. This result can follow from the fact that 
as it was mentioned before the sensitivity of the phase to the impedance changes becomes 
greater with the increase in frequency and frequencies below 10 kHz might be not sufficiently well 
suited for the phase-based monitoring of impedance changes. Still, the observed phase and 
magnitude trends clearly illustrate the system sensitivity to the electrical characteristics of the 
media the device is placed into, with the highest sensitivity observed at the lower ranges of 
conductivities below 1000 µS/cm. The conductivity of a 1000 µS/cm is exactly approximate 
beginning of the range of conductivities characteristic for the muscle tissue, which is of the 
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interest in case of the peripheral vascular disease. As it was discussed earlier, the sensitivity of 
the device would be dependent on the output port impedance of the device, which could be set to 
desired range depending on our application by incorporating the resistor or changing the 
characteristics of the device electrodes (dimensions and material). 
Wireless characterization of saline solutions. In case of the wireless measurements 
almost the same trends have been observed, including voltage RMS decrease with the increase 
in conductivity, highest sensitivity at lower range of conductivities (in this case in the range below 
1500 µS/cm) and some inconsistencies in the results at higher conductivities. The difference 
between the results shown at Fig. 37A and 37B is in the fact that in case of the wireless 
measurements the voltage RMS appeared to be increasing with the increase in baseband 
frequency. This can be somehow caused by the contribution of the Ag/AgCl electrodes used in 
the experiment, but if this would be a known characteristic of our system we still would be able to 
account and calibrate for it. This experiment also involved repeated measurements at every 
condition to account for the output variations over time. Basically the results showed that despite 
all the fluctuations the changes in output occurring with the baseband frequency sweep are still 
greater than the fluctuations present in the system. 
The key summarizing points of this experiment are the following: 
• wired and wireless interrogation experiments with saline solutions showed system 
sensitivity to the electrical parameters of the media surrounding the device; 
• the output port impedance showed again to be important in defining the highest 
sensitivity region of the neurostimulator. 
 
V. Wired and wireless characterization of tissue samples 
Wired characterization of the beef tissue samples. The results obtained from the 
experiments involving wired impedance analysis of the beef tissue samples (Fig. 38A) exhibit the 
trends similar to the discussed earlier. The magnitude is characterized by the slow decay with 
frequency, as well as highest sensitivity to the induced impedance change at low frequencies. 
Frequency dependent behavior of phase in this case does not allow differentiation between 
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different conditions. The nature of the phase changes induced by the actual physiological events 
(e.g., increase or decrease in perfusion) would actually need to be carefully examined through 
animal studies and the only thing that can be concluded from these results is that our devices are 
sensitive to changes in electrical characteristics of the sample under investigation. 
Wireless characterization of the beef tissue samples. The results of the same experiment 
with beef samples only involving wireless detection (Fig. 38B) also exhibit similar trends, but with 
significant distortions, which could be expected as now we are basically dealing with more than 
20 times weaker signals on the order of tens of microvolts and these weak signals are achieved 
using fairly high acoustic power on the order of 315 mW/cm2, leaving not so much space for 
further increase in power before reaching an FDA limit. Basically, what can be seen is that 
voltage RMS drops with increase in frequency just by about 2 µV, but the change in RMS as 
result of the introduction of solution are about 3 times greater (20% at 10 Hz). As soon as we can 
detect such changes it can be absolutely sufficient for monitoring of the physiological events. In 
case of the phase the detected change is around 1.6% at 7 kHz, but taking into account the 
expected trend of the phase to have greater change at higher frequencies, which is evident also 
from our results, the phase change and consequently the usability of the phase information is 
expected to increase with the increase in bandwidth of the baseband frequencies. 
Wireless measurements in cadaveric rat. In case of the cadaveric rat experiments much 
higher detected voltages could be achieved (Fig. 39) than in case of the experiments with beef 
samples (Fig. 38B), which might be associated with better acoustic coupling of the transducer 
with device in cadaveric rat. It must be noted that in case of the experiments with cadaveric rat 
achieving good coupling was more difficult than in the case of the beef samples stacked in the 
column because in case of the cadaveric rat there is no visual feedback about the exact position 
of the device and it was localized by looking at the readings on the lock-in amplifier. 
The experiment with cadaveric rat involved two stages. The first stage involved many 
unsuccessful trials and the results of the one of the most successful trials are shown on Fig. 39A. 
Basically, the problem encountered in these experiments was associated with much higher 
reading fluctuations than observed before. The most contributing factors to observed fluctuations 
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were transducer drift relative to the implant and crosstalk. Despite the fact that in the experiment 
with beef samples used acoustic power density and consequently driving voltage was much 
higher, which always is associated with higher crosstalk, in case of the experiments with 
cadaveric rat, the surface electrodes are placed right next to the transducer. In the experiments 
with beef samples the electrodes and transducer are separated by 40 mm high stack of beef. As 
could be expected, the level of crosstalk showed to be very significantly dependent on the 
separation distance between the detection electrodes and exciting transducer. Consequently, 
these fluctuations led to many results which look like that is shown on Fig. 39A, where the 
behavior of the RMS signal looks more similar to the noise. 
It can be argued that phase information was successfully detected and it even 
demonstrates change in phase on the order of 2% with solution injection. The problem with this 
argument is the fact that in the experiment with RC circuits even in the case when the 
capacitance was removed from the circuit, the phase still exhibited similar frequency dependent 
behavior as is observed in the experiments with tissue samples (Fig. 35B, Fig. 38A, Fig. 39A). 
Basically, this is an additional factor that would need to be accounted and calibrated for before we 
could start making any conclusions about the tissue based on the phase information. The simple 
correction by subtraction of the known phase curve characteristic for the specific device can be 
complicated by the fact that over time after the implantation device can change its characteristics 
(especially characteristics of the electrodes) and this would consequently lead to the degradation 
of measurement performance. 
Going back to the experiments with cadaveric rats, Fig. 39B illustrates the results of the 
more successful trial. The main improvement introduced into the experiment leading to the more 
reasonable results was significant reduction in the number of frequencies used to record the 
spectra. Basically, this ensured that any significant output fluctuations simply did not occur in the 
process of the experiment. This led to the spectra with similar trends that were observed in the 
experiment with beef samples (Fig. 38B). The impedance change caused by the injection of the 
solution is well detectable, although the RMS change appeared to be much greater at high 
frequency than at low frequency (64% at 35 kHz versus 11% at 10 Hz; results for high 
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frequencies are not presented in this work). The deformation of the curve at 20 kHz after solution 
injection might suggest that some not-impedance related fluctuations occurred even in the 
process of this experiment, producing distorted results. In case of the phase, detected change at 
35 kHz is ~ 4%. 
Reference measurements. It must be noted that for all performed experiments with tissue 
samples it would be very useful to incorporate reference impedance measurements performed in 
parallel to the device based measurements using the conventional impedance measurement 
technique (e.g., using the tetrapolar technique with impedance bridge). The problem with such 
reference measurements is that the stimulation electrodes must not only be placed into the same 
location as device, but also have the same dimensions and material to produce comparable 
measurements. The problems of doing such reference measurements simultaneously with device 
based measurements lies not only in the separability of two signals (this probably could be done 
by using two different baseband frequencies used to modulate the carrier and drive the reference 
stimulation electrodes), but the problem would also involve high risk of ground crosstalk (we 
basically have 4 or even 5 grounds being in contact with the sample simultaneously). It must be 
admitted that in case of the live animals such reference measurements would be even more 
difficult to perform, because it would require the powering wires to be tunneled under the skin 
delivering wired stimulation to the same location where the device is placed. 
Summarizing points. Overall, the main points and observations of these experiments can 
be summarized in the following statements: 
• wired measurements showed satisfactory results with the biological samples. This 
observation allows to conclude that all limitations of the proposed technique identified 
after transition to wireless detection can be associated with the efficacy of wireless signal 
transmission and detection, as well as information encoding to begin with (other encoding 
techniques such as FM modulation would be immune to many factors causing all the 
variability in the measurements); 
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• in addition to the previous observation from magnitude measurements, the results of the 
phase measurements discussed here showed the importance of the accounting for the 
frequency response characteristics of the device itself; 
• device proved to be sensitive to the induced impedance changes in biological samples, 
but it must be noted that changes induced on the benchtop are not equivalent to the 
changes occurring in vivo with physiological events. Additionally, any evidences of the 
ability of system to extract the absolute impedance values have not been observed yet, 
leaving the potential only for the monitoring of impedance relative changes; 
• reference impedance measurements are very desirable at least in such types of 
benchtop experiments, but to make such measurements possible a number of additional 
technical issues would need to be addressed; 
• measurement instabilities became really appreciated during the experiments with 
biological samples. This leads to several important improvements, which would need to 
be realized in the ultimate system: spectral data collection for the sample impedance 
characterization at given specific instance must be performed as fast as possible 
(recording automatization, reduction in the number of frequencies, excitation using pulsed 
waves instead of the continuous), measures must be taken against the crosstalk 
(shielding, grounding, time delays between excitation and recording), reduction of the 
directional sensitivity must be achieved (all of these factors will be further addressed in 
greater detail in the section on Live animal experiments and final summary of the study). 
 
VI. Live animal experiments 
First trials with highly focused transducer. As it was stated in the Results section, first 
trials done using big aperture highly focused transducer showed the signal detected from the 
surface of the skin to be as high as 3.3 mV. According to the experiments done on the benchtop 
such level signal would be absolutely sufficient to perform the measurements. The problem was 
in the exceptionally high directional sensitivity of the device. Basically, in order to get the signal 
on the order of millivolt about an hour long search of the peak coupling window around the rat’s 
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limb was required. After finding the right location, the signal would cease away too rapidly not 
allowing impedance spectrum recording. This ceasing could not be prevented by simply 
restraining the rat and fixating the transducer. First trials were concluded to have multiple 
problems in the setup: too highly focused transducer with too high mass and dimensions; high 
crosstalk level. In this case the highly focused commercial transducer had good shielding, but due 
to the high drive (~60 V) the resulting level of the crosstalk was still too high, preventing 
differentiation between noise and weak outputs produced by weak acoustical coupling. 
Introduced system improvements. To solve just discussed problems it was decided to 
use the unfocused transducer. Commercial unfocused transducers available in the lab were 
shown not capable of producing sufficiently high output from the devices, therefore it was decided 
to build the transducer using PZT-5H characterized by relatively good quality factor and therefore 
suitability for being used as the transmitter. First set of transducers were built simply by isolating 
the piezoelectric material with epoxy. This design was tested on the cadaveric rat and 
demonstrated unacceptably high level of crosstalk on the order of multiple millivolts. This 
crosstalk is mainly caused by the capacitive coupling of transducer with the rat and consequent 
signal leakage to the surface electrodes placed in vicinity of the transducer. It was determined 
that the nature of crosstalk is capacitive by placing the transducer at different parts of the rat. As 
soon as transducer touches the rat, the reading on the lock-in amplifier starts to increase and the 
closer transducer is located to the electrodes, the greater is level of interference. Basically, we 
have two conductors (nickel coated piezoelectric material and cadaveric rat) separated by the 
layer of epoxy forming a capacitor. It was attempted to use a higher column of acoustic coupling 
gel, which is supposed to have relatively low conductivity, but as the drive goes up the crosstalk 
becomes too high. The level of severity of the crosstalk problem follows from the fact that we are 
applying as high as 60 V driving voltages to the ultrasound exciter and are trying to measure mV 
or even sub-mV level signals using the electrodes placed about 10 mm away from the exciter. 
Basically, the ratio of the driving signal and measured signal occurring in the same location is 
greater than 104. 
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Consequently, further improvements into transducer design were introduced to reduce 
the level of crosstalk as much as possible. The design of the final version of transducers is shown 
on Fig. 9. The main introduced improvements include shielding by the grounded copper tubing 
and the mesh, as well as incorporation of the spacer made out of the steatite. Additionally, 
instead of the simple measurements done using a pair of surface electrodes, a differential 
measurement system was employed (shown on Fig. 19A).  
Trials with improved setup. Despite these improvements the level of noise in live rat was 
observed to be as high as 100 µV, whereas on average it was in the range of 20-30 µV, which 
depended on the exciting transducer relative position to the detecting electrodes. While moving 
the transducer around the implantation sight any distinct peaks could not be observed. It was also 
attempted to look into signal at the baseband harmonic, which with differential measurements 
produced 0 µV crosstalk, but again any output from the device could not be detected. This can be 
caused by the fact that device was producing voltages below diode’s threshold, although during 
benchtop testing bridge rectifiers demonstrated very good rectification performance. 
Next, in order to differentiate between the crosstalk and actual signal from the device at 
the baseband frequency, it was decided to introduce the carrier frequency sweeping. The level of 
crosstalk is not supposed to change by changing the carrier frequency (it was confirmed by 
benchtop testing), but the output signal from the device is highly dependent on the carrier 
frequency (as it was mentioned earlier, this is associated with the resonance frequencies of 
exciting and receiving transducers). The highest reading change that could be observed from live 
rat with frequency sweeping was on the order of 10% (basically 90% of signal was just the 
interference), but even these 10% was difficult to associate with actual output of the device 
because these changes can also be associated with micromotion of the exciter or receiver. 
Therefore, due to not being able to establish the baseline any impedance measurements could 
not be conducted. 
Burst excitation of the implanted device. Finally, measurements were done using the 
burst excitation (Fig. 19B) to identify if the experienced problems during the impedance 
measurements were caused by the device itself. The implant has been in the rat for 5 months and 
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can be expected not to function properly anymore. As it is shown on Fig. 39, it was possible to 
detect the signal from burst excited implant. Six different transducers were tried again and only 
two of them allowed obtaining the signals shown on Fig. 39 with maximal peak-to-peak 
magnitude of 2 mV. Based on the previous experience the signal of such magnitude would be 
absolutely sufficient for impedance measurements. Additionally, based on the reading from the 
oscilloscope this signal was fairly stable. Still, it could be identified that the coupling window of the 
device was very narrow (on the order of 10 degrees). 
Ultimate planned proof-of-feasibility experiment. The ultimate planned experiment, which 
would demonstrate if proposed system really has a potential for becoming a clinical tool, is 
illustrated on Fig. 42. Fig. 42 shows the ultimate experiment involving a number of introduced 
improvements, which, based on the observations from the experiments, would make the 
performance of the system more similar to what is expected from the ultimate clinical instrument. 
The idea behind envisioned rat experiment shown on Fig. 42 relies on the phenomenon 
called reactive hyperaemia, which involves the significant increase in the tissue perfusion as the 
consequence of having it exposed to the ischemia. The experiment would involve occlusion of the 
femoral artery supplying rat’s lower limb. This would produce the decrease in blood flow with 
consequent overshooting after the pressure is released. The blood flow was planned to be 
measured using the laser Doppler flowmeter (as in the previous work on blood flow modulation 
[2]), whereas the implant would be expected to show the opposite trend in impedance. 
As an alternative way of blood flow modulation the irritation of tissue using the capsaicin 
was considered. This relates to the additional application considered for the investigated 
technique, which involves monitoring of the blood supply and health of the nerves rather than 
muscles or other non-nervous tissue. This would require precise device placement right along the 
nerve or with sufficient size reduction even inside the nerve. Such measurements would be useful 
in case of neuropathy, for instance, caused by obesity or drugs used for pain relief (e.g., 
capsaicin) [58]. 
 
  91 
 
Fig. 42.  Schematic of the ultimate live rat experiment for testing the sensitivity of microdevices to the 
changes in blood flow. 
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Main identified problems. During the animal experiments the main identified problems are 
considered to be the directional sensitivity and crosstalk. The directional sensitivity though is 
considered to be more severe problem because it fundamentally degrades our ability to perform 
any measurements. Even if we could manage to record impedance data at several frequencies 
by stabilizing the output for 10s of seconds, we still would not be able to perform the envisioned 
experiment shown on Fig. 42 because it involves too many simultaneous interactions with the rat, 
all of which can serve as perturbations to the acoustic coupling. In the parallel project, smaller 
dimension devices showed to be less directionally sensitive and this something that must be 
systematically evaluated to identify if simple size reduction can reduce the directional sensitivity 
down to the level where it would be well tolerated by the patients and clinicians, making 
investigated system clinically applicable and attractive. Ultimately, elimination of directional 
sensitivity and ability to maintain stable acoustic coupling would make crosstalk problem less 
severe simply because the output signal from the device would become sufficiently greater than 
the crosstalk. 
Additional approaches for fighting directional sensitivity problem would involve: 
• injection of the multiple randomly oriented micrometer size devices into the same area so 
that the supplied excitation pulses would always activate at least a fraction of the 
implants; 
• driving the excitation transducer with a complex waveform, for instance, white noise (as it 
was noted from the experiments, the carrier frequency providing highest output from the 
device is dependent on the position and orientation of the device in acoustic beam. 
Hence, it could be expected that by sending in the more complex waveform you would 
get the output at bigger number of positions, although the overall peak output in such 
case would be decreased); 
• utilization of the multi-element array exciting transducer, potentially involving selection of 
the combination of the elements providing highest output from the device at given 
instance of time and space (the strength of the power generated by the implant would be 
estimated using the surface detected potentials, although alternatively the acoustic echo 
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analysis could also potentially provide similar feedback, but echo detection and analysis 
would require additional system sophistication and increase in the cost). 
Besides directional sensitivity, the problem of the data recording automatization plays an 
important role. In the clinical situation we would like to have all the data collected as fast possible 
before any perturbations can be introduced (e.g., tissue or transducer motion). Ideally even within 
a second data could be collected at multiple frequencies by using pulse excitation instead of the 
continuous waveform. Each pulse can consist of a single period of the baseband signal (Fig. 42), 
which would also eliminate the crosstalk problem by introducing time delay between the excitation 
and recording. Alternatively, the data extraction process could potentially be made even faster by 
using complex baseband waveform excitation, involving sample interrogation simultaneously at 
multiple baseband frequencies. Moreover, the data in such case could be analyzed using the 
computerized system, involving the signal analysis similar to what is done using the lock-in 
amplifier. 
Taking into account all the problems discussed, the initially planned experiment involving 
microdevice actuation by single element transducer using continuous waveform drive seems to 
be almost unfeasible, mainly because it involves multiple simultaneous interactions with the rat: 
placement of three recording electrodes, application of the ultrasound and laser probes, and 
application of the cuff for the blockage of blood flow. Basically, performance of all of these 
manipulations without even slightest movements of the animal is almost impossible, but even if 
the coupling of the exciter and receiver could be maintained stable in such experiment, the 
system would still remain clinically inapplicable until all discussed problems would be addressed. 
Summary of the animal experiments. Overall, animal experiments allowed identification of 
many limitations of the proposed system, which would need to be dealt with before final proof of 
feasibility of proposed system for wireless impedance measurements. Findings of the animal 
experiments can be summarized in the following key points: 
• the implant was proven to maintain functionality over as long time period as 5 months 
after the implantation; 
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• in case of the continuous waveform drive, the carrier frequency sweeping has shown to 
allow differentiation between noise and device output signal; 
• the utilization of the highly focused ultrasound transducer demonstrated the high efficacy 
of power delivery to the implant, providing easily detectable signal from the skin surface, 
but the directional sensitivity with focused transducer and PZT receiver of dimensions on 
the order of 1 mm was observed to be unacceptably high (sensitivity window narrows 
down to a few degrees); 
• the issue of directional sensitivity of the ultrasonically powered microdevices must be 
addressed in order to make these devices potentially clinically applicable and to make 
possible the proof-of-feasibility of the investigated wireless impedance measurement 
technique; 
• the data collection must be automatized in order to reduce the effects of the transient 
environmental factors (e.g., motion induced changes in transducer or electrode coupling); 
• high drive on the transducer exceeding the detected signal by about 104 times results in 
high crosstalk level, characteristic for the continuous waveform driving; 
• implant excitation must be optimized to allow faster data collection.  The transition from 
continuous excitation to pulsed excitation should reduce the time required for spectral 
recording, as well as elimination of the noise, allowing clear separation of the interference 
and the signal of interest. Alternatively, it would be preferable to perform the transition 
from amplitude encoding of the impedance information to other forms of encoding, not so 
dependent on relative positioning and coupling. 
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CHAPTER 6 
SUMMARY AND CONSIDERATIONS FOR FUTURE WORK 
Proposed and investigated technique aims at wireless tissue electrical impedance 
measurements using ultrasonically powered microdevices. This work serves as the first step 
towards proving feasibility and clinical applicability of this technique. Benchtop testing and 
preliminary animal experiments allowed identification of the key problems, which must be 
addressed before proposed technique can be concluded as feasible for wireless tissue 
impedance monitoring based clinical applications. 
A number of questions have been identified in the process of this work, requiring further 
investigation. For efficient neurostimulation and impedance measurements, full system 
optimization would be necessary: 
• rectification optimization (requires systematic analysis of the different types of rectifiers 
and their connection configurations). As an example of attractive rectification approach 
can be considered the rectification produced by the electrodes themselves (by using 
appropriately selected materials); 
• external exciter optimization (consideration of the transducer physical parameters, 
including the resonance frequency, bandwidth, focusing, excitation mode, number of the 
elements in array, acoustic impedance matching). The attractiveness of the pulse 
excitation for impedance measurements has been highlighted in this work, allowing 
separation of the signal of interest from the crosstalk, as well as higher power delivery to 
the implant. Array transducer would have the advantage not only in its ability to reduce 
the directional sensitivity of the implants, but through beam steering it also has a potential 
for multi-channel functionality. Furthermore, based on the approach discussed in [8], 
beam steering would allow much more efficient localization of the implant. Knowledge of 
the geometry of system components (implant relative position to the surface electrodes) 
and tissue impedance, could allow more precise estimation of the currents produced by 
the implant; 
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• implantable receiver optimization (receiver dimensions, loading, type of piezoelectric 
material); 
• data recording, post-processing and analysis optimization (requires fast data collection 
and automated analysis). Data analysis would also need to deal with the interference 
produced by the electromyographic activity present in the baseband frequency range. 
The potential problems associated with muscular activity make the radio receiving 
approach more attractive, as it would be insensitive to these types of interference 
because the signals used for data extraction are in the carrier frequency region; 
• stimulation optimization (selection of the right driving waveform parameters, charge 
balancing, electrode material and dimensions); 
• detection optimization (deeper analysis of the surface electrodes based detection versus 
wireless detection using the antenna and radio receiver). 
The safety concerns associated with ultrasound and application of the electrical currents 
to the tissue have not been discussed in great details throughout this work, but these questions 
would be of the key importance if investigated technique would ever reach the FDA approval 
process. One of the briefly discussed questions is related to the control of the current applied to 
tissue. Simulations have shown the natural ability of the Schottky diode connected in series to 
piezoelectric element to provide limitation of the stimulatory currents. This is achieved by reduced 
rectification efficiency with increase in applied voltages. If the same device would be used both 
for neurostimulation and impedance measurements, an important issue would be an efficient 
control of the impedance measuring currents, which due to the rectification are capable to cause 
nerve excitation. The only factor that would prevent stimulation by impedance measuring currents 
is restricted magnitude of these interrogative currents, which must be maintained below neural 
stimulation threshold. 
One of the critical questions relates to the biological processes occurring after the 
implantation. The key process would be the scar tissue formation as result of the introduction of 
the foreign body into tissue. It is not known yet if formation of the scar tissue encapsulation 
around the implant would make it insensitive to the physiological changes occurring outside the 
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region of scar tissue. Previously explanted devices (after the year since the implantation) of the 
type and scale used in the present work have not shown evidences of the formation of extensive 
masses of scar tissue. Additionally, as it was discussed in [10], the tissue response is highly 
dependent on dimensions of the implant and as the dimensions become smaller, tissue response 
decreases proportionally. Moreover, this issue could also be addressed by using special coatings, 
which can reduce tissue response and potentially lead to the reduced scar tissue formation (e.g., 
PEG coating). 
Another potential long-term issue can be related to the impedance changes of the 
implant’s electrodes. It is difficult to estimate the course of such impedance changes and at this 
point it does not seem possible to correct for such changes. Therefore, as possible solutions 
different electrode materials and dimensions can be explored to mitigate this issue. 
Alternative impedance measurement techniques would need to be considered if the 
problems associated with technique investigated in this work cannot be mitigated down to the 
acceptable levels. For instance, as an alternative wireless tissue bioimpedance measurement 
technique can be considered the approach based on the utilization of epidermal high frequency 
currents as discussed in [32]. In its basic form this technique can involve implantation of the 
microrectifiers serving for signal demodulation, current injection using surface electrodes, and 
consequent detection of the rectified currents using the same electrodes. The key potential 
benefits of such approach would include elimination of the orientation and position sensitivity 
problems associated with acoustic powering. This approach would also allow to get rid of the 
requirement for physical coupling, as well as would simplify device structure by eliminating need 
for piezoelectric material. This approach might be overlooked as the more complicated and more 
invasive version of the conventional impedance measurement technique, but the key benefit 
would involve the ability to perform more chronic and more localized impedance measurements 
at specific location of interest in the tissue. 
In addition to exploration of the alternative wireless impedance measurement 
approaches, it is important to think about complementary potential applications for investigated 
technique, besides the discussed peripheral vascular disease. The most attractive application 
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seems to be the monitoring of the neural activity, discussed in greater details in [56-57]. 
Extensive work has been done on neural activity monitoring using the electrical impedance 
tomography (EIT). At this point, this application still is considered to be feasible, and it offers a 
potential for reaching the “holy grail” of monitoring neural activity non-invasively with a time and 
spatial resolution of about 1 ms and 1 mm respectively. EIT based neural activity monitoring 
technique still involves many challenges and these challenges would become only magnified if 
we try to apply presently investigated wireless impedance measurement technique for neural 
activity monitoring. Some of the problems would be associated with the fact that this application is 
considered to require interrogative currents of the sub-threshold magnitude on the order of 1-10 
µA. In our experiments generated currents have not been exactly estimated, but from previous 
work [2] the maximal currents generated by our devices were estimated to be on the order of 1 
mA. Therefore, currents used in all the experiments in this work must be much greater than 10 
µA. Still, even with higher currents wireless signal detection using surface electrodes proved to 
be challenging. Additionally, so far reported resistance changes with action potentials are around 
1% or even lower, and some of the researchers used signal averaging over as long periods as 1 
minute to perform such measurements. Both of these factors emphasize the severity of the 
baseline variability problem widely discussed in this work. Even with conventional EIT 
measurements the encountered baseline variability can be on the order of 1-2%, resulting in SNR 
of 2-3 [57]. These issues present even in the sophisticated multi-electrode EIT measurement 
systems are indicative of how challenging wireless extraction of neural activity related impedance 
information can be. 
Ultimately, the feasibility study of the single device allowing triple functionality 
(neurostimulation, impedance measurements, neural recording) would need to be done. The idea 
of the triple functionality of the single wireless microimplant is very attractive due to the high 
benefits for the patients. These benefits can include reduced injury and pain, as well as absence 
of the tethering wires allowing not only the more unconstrained patient motion, but also leading to 
the better stability and quality of neurostimulation and recording. Present work suggested two 
potential approaches for wireless neural recording. One approach relies on structural device 
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modification, involving rectifier replacement with varicap type rectifier. The second approach 
relies on the measurements of transient impedance changes associated with neural events. 
At the present stage ultrasonically powered implantable microdevices clearly 
demonstrate the potential of being applicable for wireless bioimpedance measurements. These 
devices have shown to be sensitive to impedance changes of the media surrounding them. Still, 
final conclusion about the feasibility and clinical applicability of investigated technique would 
depend on its ability to extract physiologically relevant information in reliable, safe and convenient 
way. Present work provides the insights into questions, which would need to be addressed in the 
future studies, and can be considered as a first step in development of the new clinical tool for 
wireless bioimpedance monitoring.  
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